Gene Symbol | Gene ID | Gene Info |
---|---|---|
Klf6
|
ENSMUSG00000000078.6 | Kruppel-like factor 6 |
Patz1
|
ENSMUSG00000020453.11 | POZ (BTB) and AT hook containing zinc finger 1 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr13_5864707_5864858 | Klf6 | 104 | 0.961227 | -0.46 | 4.5e-04 | Click! |
chr13_5861092_5861858 | Klf6 | 7 | 0.972123 | -0.33 | 1.2e-02 | Click! |
chr13_5870421_5870589 | Klf6 | 5827 | 0.170711 | -0.33 | 1.4e-02 | Click! |
chr13_5875581_5875732 | Klf6 | 10978 | 0.153748 | -0.31 | 2.0e-02 | Click! |
chr13_5869984_5870137 | Klf6 | 5382 | 0.173839 | -0.31 | 2.2e-02 | Click! |
chr11_3293306_3293481 | Patz1 | 525 | 0.665532 | 0.56 | 8.8e-06 | Click! |
chr11_3292685_3293228 | Patz1 | 88 | 0.948822 | 0.46 | 4.3e-04 | Click! |
chr11_3302910_3303074 | Patz1 | 4708 | 0.124215 | -0.39 | 3.6e-03 | Click! |
chr11_3285315_3285466 | Patz1 | 3484 | 0.147450 | -0.20 | 1.4e-01 | Click! |
chr11_3299098_3299249 | Patz1 | 889 | 0.441724 | 0.17 | 2.2e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr19_61225302_61226760 | 44.52 |
Csf2ra |
colony stimulating factor 2 receptor, alpha, low-affinity (granulocyte-macrophage) |
541 |
0.67 |
chr7_29210966_29212124 | 24.18 |
Catsperg1 |
cation channel sperm associated auxiliary subunit gamma 1 |
50 |
0.94 |
chr9_53705535_53706804 | 15.35 |
Rab39 |
RAB39, member RAS oncogene family |
63 |
0.96 |
chr2_33130296_33131698 | 15.17 |
Garnl3 |
GTPase activating RANGAP domain-like 3 |
389 |
0.84 |
chr12_3236518_3237725 | 14.80 |
Rab10os |
RAB10, member RAS oncogene family, opposite strand |
510 |
0.74 |
chr14_120830371_120830865 | 14.25 |
Gm9391 |
predicted gene 9391 |
3460 |
0.2 |
chr9_91365711_91366045 | 13.89 |
Zic1 |
zinc finger protein of the cerebellum 1 |
68 |
0.95 |
chr9_86879639_86880662 | 13.85 |
Snap91 |
synaptosomal-associated protein 91 |
247 |
0.94 |
chr7_44310178_44311500 | 13.68 |
Shank1 |
SH3 and multiple ankyrin repeat domains 1 |
586 |
0.43 |
chr14_5961062_5962084 | 13.38 |
Gm3248 |
predicted gene 3248 |
172 |
0.91 |
chr15_76519858_76520192 | 12.99 |
Scrt1 |
scratch family zinc finger 1 |
1877 |
0.14 |
chr14_14345884_14346978 | 12.57 |
Il3ra |
interleukin 3 receptor, alpha chain |
1 |
0.93 |
chr10_81472309_81472908 | 12.34 |
Celf5 |
CUGBP, Elav-like family member 5 |
394 |
0.64 |
chr4_22488420_22489023 | 12.29 |
Pou3f2 |
POU domain, class 3, transcription factor 2 |
355 |
0.83 |
chr18_36195864_36196404 | 12.20 |
Nrg2 |
neuregulin 2 |
1098 |
0.56 |
chr2_73385763_73387080 | 11.78 |
Gpr155 |
G protein-coupled receptor 155 |
9 |
0.9 |
chr3_88205532_88206477 | 11.71 |
Gm3764 |
predicted gene 3764 |
809 |
0.34 |
chr9_64671680_64672182 | 11.66 |
Megf11 |
multiple EGF-like-domains 11 |
11472 |
0.21 |
chr14_14349938_14350878 | 11.47 |
Il3ra |
interleukin 3 receptor, alpha chain |
787 |
0.48 |
chr5_109556763_109557843 | 11.43 |
Crlf2 |
cytokine receptor-like factor 2 |
830 |
0.53 |
chr5_112577448_112578314 | 11.43 |
Sez6l |
seizure related 6 homolog like |
696 |
0.62 |
chr14_3208167_3209194 | 11.30 |
D830030K20Rik |
RIKEN cDNA D830030K20 gene |
103 |
0.95 |
chr1_93176328_93177269 | 11.23 |
Crocc2 |
ciliary rootlet coiled-coil, rootletin family member 2 |
8073 |
0.13 |
chr16_44687184_44688343 | 11.00 |
Nepro |
nucleolus and neural progenitor protein |
36538 |
0.14 |
chr9_122571793_122572853 | 10.90 |
9530059O14Rik |
RIKEN cDNA 9530059O14 gene |
176 |
0.93 |
chr12_112721309_112722969 | 10.72 |
Cep170b |
centrosomal protein 170B |
35 |
0.95 |
chr17_93203734_93203963 | 10.70 |
Adcyap1 |
adenylate cyclase activating polypeptide 1 |
1772 |
0.34 |
chr5_37242202_37242734 | 10.62 |
Crmp1 |
collapsin response mediator protein 1 |
266 |
0.92 |
chr7_81454347_81455042 | 10.60 |
Cpeb1 |
cytoplasmic polyadenylation element binding protein 1 |
19 |
0.95 |
chr4_22479124_22479682 | 10.47 |
Pou3f2 |
POU domain, class 3, transcription factor 2 |
8963 |
0.17 |
chr17_35836572_35837313 | 10.41 |
Tubb5 |
tubulin, beta 5 class I |
118 |
0.89 |
chr7_16129395_16130325 | 10.36 |
Slc8a2 |
solute carrier family 8 (sodium/calcium exchanger), member 2 |
34 |
0.96 |
chr9_122294282_122295077 | 10.26 |
Ano10 |
anoctamin 10 |
256 |
0.84 |
chr10_70599218_70599723 | 10.22 |
Phyhipl |
phytanoyl-CoA hydroxylase interacting protein-like |
179 |
0.96 |
chr5_25498778_25500023 | 10.19 |
Kmt2c |
lysine (K)-specific methyltransferase 2C |
617 |
0.62 |
chr2_24664760_24664948 | 10.13 |
Gm13459 |
predicted gene 13459 |
9847 |
0.17 |
chrX_13346707_13347908 | 10.04 |
Gm7129 |
predicted gene 7129 |
20288 |
0.14 |
chr14_4110111_4111235 | 9.96 |
Gm8108 |
predicted gene 8108 |
147 |
0.94 |
chr5_37028527_37029187 | 9.94 |
Jakmip1 |
janus kinase and microtubule interacting protein 1 |
255 |
0.91 |
chr14_5000842_5001422 | 9.93 |
Gm3298 |
predicted gene 3298 |
14759 |
0.13 |
chr7_6729309_6729829 | 9.83 |
Peg3 |
paternally expressed 3 |
850 |
0.28 |
chr14_4726126_4727100 | 9.79 |
Gm3252 |
predicted gene 3252 |
162 |
0.93 |
chr8_70315603_70316677 | 9.76 |
Cers1 |
ceramide synthase 1 |
353 |
0.75 |
chr7_79535477_79536145 | 9.75 |
Gm35040 |
predicted gene, 35040 |
232 |
0.85 |
chr1_21078652_21079573 | 9.51 |
Tram2 |
translocating chain-associating membrane protein 2 |
117 |
0.93 |
chr10_83722468_83723424 | 9.50 |
1500009L16Rik |
RIKEN cDNA 1500009L16 gene |
20 |
0.98 |
chr12_61522794_61523620 | 9.49 |
Lrfn5 |
leucine rich repeat and fibronectin type III domain containing 5 |
40 |
0.97 |
chr9_124439906_124440949 | 9.48 |
Ppp2r3d |
protein phosphatase 2 (formerly 2A), regulatory subunit B'', delta |
441 |
0.79 |
chr9_26733143_26733768 | 9.44 |
B3gat1 |
beta-1,3-glucuronyltransferase 1 (glucuronosyltransferase P) |
273 |
0.88 |
chr14_34819764_34820558 | 9.42 |
Grid1 |
glutamate receptor, ionotropic, delta 1 |
53 |
0.98 |
chr14_6037512_6038662 | 9.35 |
Gm8206 |
predicted gene 8206 |
122 |
0.93 |
chr15_66239660_66240017 | 9.34 |
Kcnq3 |
potassium voltage-gated channel, subfamily Q, member 3 |
46213 |
0.14 |
chr7_118593842_118594498 | 9.34 |
B230311B06Rik |
RIKEN cDNA B230311B06 gene |
1654 |
0.28 |
chr14_7567758_7569131 | 9.24 |
Gm3558 |
predicted gene 3558 |
122 |
0.95 |
chr14_68085030_68085228 | 9.23 |
Nefl |
neurofilament, light polypeptide |
1266 |
0.44 |
chr15_18818564_18819019 | 9.10 |
C030047K22Rik |
RIKEN cDNA C030047K22 gene |
17 |
0.67 |
chr13_78200366_78200817 | 9.10 |
A830082K12Rik |
RIKEN cDNA A830082K12 gene |
813 |
0.37 |
chr9_16499601_16499992 | 9.04 |
Fat3 |
FAT atypical cadherin 3 |
1489 |
0.55 |
chr5_121836427_121837736 | 8.91 |
Sh2b3 |
SH2B adaptor protein 3 |
222 |
0.86 |
chr14_111675429_111676589 | 8.73 |
Slitrk5 |
SLIT and NTRK-like family, member 5 |
160 |
0.96 |
chr3_34649198_34650117 | 8.60 |
Sox2 |
SRY (sex determining region Y)-box 2 |
748 |
0.5 |
chr17_45548642_45549512 | 8.58 |
Tmem151b |
transmembrane protein 151B |
600 |
0.55 |
chr8_4216526_4217378 | 8.56 |
Prr36 |
proline rich 36 |
40 |
0.94 |
chr14_60086355_60087362 | 8.51 |
Atp8a2 |
ATPase, aminophospholipid transporter-like, class I, type 8A, member 2 |
24 |
0.73 |
chr9_22051033_22052180 | 8.50 |
Elavl3 |
ELAV like RNA binding protein 3 |
404 |
0.67 |
chr14_3048629_3049241 | 8.48 |
Gm2897 |
predicted gene 2897 |
350 |
0.83 |
chr5_116569863_116570037 | 8.47 |
Gm42854 |
predicted gene 42854 |
3545 |
0.23 |
chr1_89069533_89070748 | 8.37 |
Sh3bp4 |
SH3-domain binding protein 4 |
275 |
0.91 |
chr5_24482511_24483721 | 8.33 |
Agap3 |
ArfGAP with GTPase domain, ankyrin repeat and PH domain 3 |
2944 |
0.12 |
chr8_55940261_55940432 | 8.28 |
Glra3 |
glycine receptor, alpha 3 subunit |
114 |
0.97 |
chrX_105391659_105392013 | 8.24 |
5330434G04Rik |
RIKEN cDNA 5330434G04 gene |
60 |
0.97 |
chr6_122486412_122487163 | 8.23 |
Rimklb |
ribosomal modification protein rimK-like family member B |
282 |
0.86 |
chr7_63444022_63445137 | 8.15 |
4930554H23Rik |
RIKEN cDNA 4930554H23 gene |
50 |
0.67 |
chr15_54919929_54920282 | 8.12 |
Enpp2 |
ectonucleotide pyrophosphatase/phosphodiesterase 2 |
20 |
0.98 |
chr14_39473001_39473750 | 8.05 |
Nrg3 |
neuregulin 3 |
287 |
0.95 |
chr2_97467028_97467474 | 8.01 |
Lrrc4c |
leucine rich repeat containing 4C |
406 |
0.92 |
chr11_6599159_6600158 | 8.00 |
Nacad |
NAC alpha domain containing |
266 |
0.81 |
chr1_44101573_44102245 | 7.98 |
Tex30 |
testis expressed 30 |
104 |
0.94 |
chr1_63994348_63994550 | 7.98 |
Gm13749 |
predicted gene 13749 |
29722 |
0.16 |
chr14_7244047_7245236 | 7.93 |
Gm5456 |
predicted gene 5456 |
3199 |
0.18 |
chr6_88938539_88938713 | 7.90 |
4933427D06Rik |
RIKEN cDNA 4933427D06 gene |
12057 |
0.13 |
chr15_100614796_100615700 | 7.89 |
Dazap2 |
DAZ associated protein 2 |
101 |
0.53 |
chr13_15462780_15463366 | 7.82 |
Gli3 |
GLI-Kruppel family member GLI3 |
162 |
0.76 |
chr11_54303609_54304215 | 7.81 |
Acsl6 |
acyl-CoA synthetase long-chain family member 6 |
93 |
0.96 |
chr7_84409236_84410328 | 7.78 |
Arnt2 |
aryl hydrocarbon receptor nuclear translocator 2 |
101 |
0.96 |
chr3_127627760_127627937 | 7.75 |
Neurog2 |
neurogenin 2 |
5287 |
0.13 |
chr1_153641449_153641897 | 7.73 |
Rgs8 |
regulator of G-protein signaling 8 |
11352 |
0.15 |
chr6_119847609_119848667 | 7.69 |
Erc1 |
ELKS/RAB6-interacting/CAST family member 1 |
4 |
0.98 |
chr13_83869057_83869227 | 7.68 |
2810049E08Rik |
RIKEN cDNA 2810049E08 gene |
22066 |
0.18 |
chr7_100894127_100895001 | 7.68 |
Arhgef17 |
Rho guanine nucleotide exchange factor (GEF) 17 |
126 |
0.95 |
chr7_109010582_109011352 | 7.67 |
Tub |
tubby bipartite transcription factor |
142 |
0.95 |
chr14_6756349_6757421 | 7.67 |
Gm3636 |
predicted gene 3636 |
14553 |
0.14 |
chr18_43687278_43687971 | 7.67 |
Jakmip2 |
janus kinase and microtubule interacting protein 2 |
1 |
0.98 |
chr14_5880011_5880704 | 7.66 |
Gm8237 |
predicted gene 8237 |
25 |
0.96 |
chr16_42575508_42575977 | 7.60 |
Gm49739 |
predicted gene, 49739 |
88184 |
0.1 |
chr3_81036815_81037237 | 7.59 |
Pdgfc |
platelet-derived growth factor, C polypeptide |
146 |
0.95 |
chr1_84890058_84890401 | 7.58 |
Fbxo36 |
F-box protein 36 |
21078 |
0.13 |
chr10_57784677_57785037 | 7.58 |
Fabp7 |
fatty acid binding protein 7, brain |
24 |
0.97 |
chr18_45016336_45016496 | 7.57 |
Gm31706 |
predicted gene, 31706 |
28446 |
0.16 |
chr14_57525179_57526034 | 7.50 |
Il17d |
interleukin 17D |
829 |
0.55 |
chr18_25661760_25662086 | 7.50 |
0710001A04Rik |
RIKEN cDNA 0710001A04 gene |
51847 |
0.14 |
chr18_25582908_25583396 | 7.47 |
Gm3227 |
predicted gene 3227 |
14338 |
0.27 |
chr16_87698379_87699046 | 7.47 |
Bach1 |
BTB and CNC homology 1, basic leucine zipper transcription factor 1 |
233 |
0.94 |
chr18_67464673_67465310 | 7.43 |
Prelid3a |
PRELI domain containing 3A |
100 |
0.95 |
chr12_98900589_98901909 | 7.40 |
Eml5 |
echinoderm microtubule associated protein like 5 |
77 |
0.97 |
chr6_120294093_120295041 | 7.39 |
B4galnt3 |
beta-1,4-N-acetyl-galactosaminyl transferase 3 |
8 |
0.98 |
chr4_124906563_124906798 | 7.38 |
Epha10 |
Eph receptor A10 |
7278 |
0.11 |
chr2_93187957_93189155 | 7.38 |
Trp53i11 |
transformation related protein 53 inducible protein 11 |
635 |
0.76 |
chr8_4238910_4239597 | 7.37 |
Gm49320 |
predicted gene, 49320 |
388 |
0.44 |
chr1_132880253_132881745 | 7.33 |
Lrrn2 |
leucine rich repeat protein 2, neuronal |
644 |
0.72 |
chr4_137727683_137728235 | 7.31 |
Rap1gap |
Rap1 GTPase-activating protein |
197 |
0.94 |
chr9_91355296_91356130 | 7.31 |
A730094K22Rik |
RIKEN cDNA A730094K22 gene |
4760 |
0.12 |
chr19_10413660_10414496 | 7.30 |
Syt7 |
synaptotagmin VII |
10060 |
0.14 |
chr16_18629072_18630255 | 7.30 |
Septin5 |
septin 5 |
41 |
0.96 |
chr14_3948585_3949537 | 7.30 |
Gm3095 |
predicted gene 3095 |
14486 |
0.11 |
chr1_3671269_3672324 | 7.27 |
Xkr4 |
X-linked Kx blood group related 4 |
298 |
0.89 |
chr4_41684547_41684815 | 7.23 |
Cntfr |
ciliary neurotrophic factor receptor |
10761 |
0.09 |
chr6_22874878_22875647 | 7.21 |
Ptprz1 |
protein tyrosine phosphatase, receptor type Z, polypeptide 1 |
240 |
0.94 |
chr11_47988672_47989535 | 7.21 |
Sgcd |
sarcoglycan, delta (dystrophin-associated glycoprotein) |
134 |
0.98 |
chr4_120854573_120855281 | 7.21 |
Rims3 |
regulating synaptic membrane exocytosis 3 |
108 |
0.95 |
chr6_127768794_127769871 | 7.19 |
Prmt8 |
protein arginine N-methyltransferase 8 |
140 |
0.91 |
chr14_4181957_4182899 | 7.17 |
Gm2974 |
predicted gene 2974 |
148 |
0.94 |
chr2_21141496_21142565 | 7.16 |
Gm13377 |
predicted gene 13377 |
76 |
0.97 |
chr13_34129793_34130880 | 7.15 |
Tubb2b |
tubulin, beta 2B class IIB |
18 |
0.96 |
chr2_165791186_165791337 | 7.11 |
Eya2 |
EYA transcriptional coactivator and phosphatase 2 |
22075 |
0.17 |
chr7_40898695_40899783 | 7.11 |
Vstm2b |
V-set and transmembrane domain containing 2B |
39 |
0.91 |
chr2_173658978_173659962 | 7.09 |
Ppp4r1l-ps |
protein phosphatase 4, regulatory subunit 1-like, pseudogene |
34 |
0.8 |
chr15_85576538_85576693 | 7.05 |
Wnt7b |
wingless-type MMTV integration site family, member 7B |
1455 |
0.36 |
chr12_3891760_3892416 | 7.03 |
Dnmt3a |
DNA methyltransferase 3A |
344 |
0.86 |
chr9_72924923_72926161 | 7.03 |
Pygo1 |
pygopus 1 |
103 |
0.93 |
chr13_28810739_28811035 | 7.03 |
Gm17528 |
predicted gene, 17528 |
16236 |
0.19 |
chr10_76961851_76962568 | 7.02 |
Pcbp3 |
poly(rC) binding protein 3 |
322 |
0.87 |
chr10_81464661_81465630 | 7.02 |
Gm16105 |
predicted gene 16105 |
3986 |
0.08 |
chr5_129724468_129725740 | 7.00 |
Nipsnap2 |
nipsnap homolog 2 |
3 |
0.95 |
chr7_45865731_45866731 | 6.96 |
Grin2d |
glutamate receptor, ionotropic, NMDA2D (epsilon 4) |
898 |
0.32 |
chr17_56472537_56473329 | 6.95 |
Ptprs |
protein tyrosine phosphatase, receptor type, S |
1694 |
0.3 |
chr5_23675895_23676511 | 6.93 |
Srpk2 |
serine/arginine-rich protein specific kinase 2 |
152 |
0.84 |
chrX_74282355_74283413 | 6.90 |
Taz |
tafazzin |
37 |
0.86 |
chr3_36862669_36863444 | 6.88 |
4932438A13Rik |
RIKEN cDNA 4932438A13 gene |
48 |
0.98 |
chr10_81429712_81431957 | 6.87 |
Nfic |
nuclear factor I/C |
171 |
0.85 |
chr4_101068780_101069771 | 6.85 |
Raver2 |
ribonucleoprotein, PTB-binding 2 |
204 |
0.93 |
chr2_152094889_152095634 | 6.84 |
Srxn1 |
sulfiredoxin 1 homolog (S. cerevisiae) |
10255 |
0.13 |
chr17_56487709_56487889 | 6.84 |
Ptprs |
protein tyrosine phosphatase, receptor type, S |
11316 |
0.14 |
chr7_81673482_81673661 | 6.84 |
Gm26149 |
predicted gene, 26149 |
3843 |
0.17 |
chr13_54749182_54749477 | 6.83 |
Gprin1 |
G protein-regulated inducer of neurite outgrowth 1 |
340 |
0.81 |
chr14_3809454_3810456 | 6.83 |
Gm3002 |
predicted gene 3002 |
119 |
0.95 |
chr1_22806069_22806442 | 6.80 |
Rims1 |
regulating synaptic membrane exocytosis 1 |
261 |
0.95 |
chr7_38106770_38108111 | 6.80 |
Ccne1 |
cyclin E1 |
62 |
0.97 |
chr2_165211032_165211191 | 6.78 |
Cdh22 |
cadherin 22 |
23742 |
0.14 |
chr2_156613304_156613799 | 6.75 |
Gm14169 |
predicted gene 14169 |
129 |
0.52 |
chr17_25809079_25809913 | 6.73 |
Fbxl16 |
F-box and leucine-rich repeat protein 16 |
411 |
0.54 |
chr16_35587590_35588108 | 6.72 |
Gm5963 |
predicted pseudogene 5963 |
14293 |
0.18 |
chr7_3411029_3411836 | 6.71 |
Gm23450 |
predicted gene, 23450 |
3634 |
0.11 |
chr10_51015016_51015208 | 6.70 |
Sim1 |
single-minded family bHLH transcription factor 1 |
119461 |
0.06 |
chr13_83739197_83739995 | 6.70 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
733 |
0.33 |
chr8_38659834_38660188 | 6.70 |
Gm40493 |
predicted gene, 40493 |
248 |
0.91 |
chr2_65022121_65023287 | 6.64 |
Grb14 |
growth factor receptor bound protein 14 |
78 |
0.98 |
chr3_17319141_17319707 | 6.64 |
Gm30340 |
predicted gene, 30340 |
15001 |
0.21 |
chr14_62836918_62838216 | 6.61 |
Wdfy2 |
WD repeat and FYVE domain containing 2 |
111 |
0.55 |
chr7_79500200_79500418 | 6.59 |
Mir9-3hg |
Mir9-3 host gene |
188 |
0.88 |
chr5_112041311_112041693 | 6.56 |
Gm42488 |
predicted gene 42488 |
97267 |
0.07 |
chr6_124662386_124663703 | 6.54 |
Lpcat3 |
lysophosphatidylcholine acyltransferase 3 |
17 |
0.95 |
chr1_172049306_172049831 | 6.52 |
Nhlh1 |
nescient helix loop helix 1 |
8005 |
0.11 |
chr15_83765468_83765992 | 6.52 |
Mpped1 |
metallophosphoesterase domain containing 1 |
13737 |
0.21 |
chr14_5070417_5071423 | 6.51 |
Gm8281 |
predicted gene, 8281 |
120 |
0.95 |
chr5_128600051_128600427 | 6.50 |
Fzd10os |
frizzled class receptor 10, opposite strand |
415 |
0.57 |
chr2_38424519_38425045 | 6.47 |
Gm13589 |
predicted gene 13589 |
780 |
0.59 |
chr10_96955859_96956119 | 6.46 |
Gm33981 |
predicted gene, 33981 |
2882 |
0.33 |
chr2_55436835_55437680 | 6.44 |
Kcnj3 |
potassium inwardly-rectifying channel, subfamily J, member 3 |
92 |
0.98 |
chr19_10041145_10042475 | 6.44 |
Fads3 |
fatty acid desaturase 3 |
78 |
0.96 |
chr7_79497714_79498195 | 6.43 |
Mir9-3hg |
Mir9-3 host gene |
2072 |
0.16 |
chr17_25803191_25803511 | 6.40 |
Fbxl16 |
F-box and leucine-rich repeat protein 16 |
5734 |
0.05 |
chr16_33605736_33606716 | 6.39 |
Slc12a8 |
solute carrier family 12 (potassium/chloride transporters), member 8 |
9599 |
0.26 |
chr9_119980991_119982157 | 6.38 |
Csrnp1 |
cysteine-serine-rich nuclear protein 1 |
1449 |
0.22 |
chr6_136173009_136173858 | 6.33 |
Grin2b |
glutamate receptor, ionotropic, NMDA2B (epsilon 2) |
56 |
0.85 |
chr9_13246797_13247848 | 6.32 |
Ccdc82 |
coiled-coil domain containing 82 |
340 |
0.82 |
chr15_26308701_26309304 | 6.30 |
Marchf11 |
membrane associated ring-CH-type finger 11 |
46 |
0.99 |
chr13_53475837_53476188 | 6.30 |
Msx2 |
msh homeobox 2 |
2938 |
0.26 |
chr12_112802292_112802867 | 6.29 |
Ahnak2 |
AHNAK nucleoprotein 2 |
78 |
0.95 |
chr7_143748420_143748925 | 6.29 |
Osbpl5 |
oxysterol binding protein-like 5 |
6709 |
0.12 |
chr6_124856418_124856707 | 6.23 |
P3h3 |
prolyl 3-hydroxylase 3 |
1167 |
0.24 |
chr8_12873206_12874084 | 6.22 |
Mcf2l |
mcf.2 transforming sequence-like |
161 |
0.92 |
chr17_57105247_57106121 | 6.19 |
Gm11110 |
predicted gene 11110 |
72 |
0.8 |
chr7_34812238_34813108 | 6.18 |
Chst8 |
carbohydrate sulfotransferase 8 |
1 |
0.98 |
chr15_64311804_64313067 | 6.17 |
Asap1 |
ArfGAP with SH3 domain, ankyrin repeat and PH domain1 |
204 |
0.93 |
chr4_59548682_59549911 | 6.16 |
Ptbp3 |
polypyrimidine tract binding protein 3 |
1 |
0.64 |
chr14_52010292_52011175 | 6.15 |
Zfp219 |
zinc finger protein 219 |
149 |
0.89 |
chr17_46680285_46681192 | 6.13 |
Mea1 |
male enhanced antigen 1 |
43 |
0.49 |
chr2_180889406_180890514 | 6.11 |
Gm14342 |
predicted gene 14342 |
300 |
0.8 |
chr18_25548275_25548710 | 6.10 |
Celf4 |
CUGBP, Elav-like family member 4 |
47253 |
0.16 |
chr4_91371091_91372260 | 6.08 |
Elavl2 |
ELAV like RNA binding protein 1 |
281 |
0.88 |
chrX_151169253_151169662 | 6.07 |
Gm15138 |
predicted gene 15138 |
243 |
0.89 |
chr13_73041587_73041766 | 6.07 |
Rpl31-ps2 |
ribosomal protein L31, pseudogene 2 |
191719 |
0.03 |
chr13_84059070_84059621 | 6.06 |
Gm17750 |
predicted gene, 17750 |
5427 |
0.24 |
chrX_150812603_150813957 | 6.03 |
Maged2 |
melanoma antigen, family D, 2 |
126 |
0.95 |
chr14_3571400_3572424 | 6.03 |
Gm3005 |
predicted gene 3005 |
111 |
0.96 |
chrX_60831373_60831817 | 6.01 |
Gm14660 |
predicted gene 14660 |
13387 |
0.19 |
chrX_49480554_49480737 | 6.01 |
Arhgap36 |
Rho GTPase activating protein 36 |
5030 |
0.25 |
chr2_106193854_106194042 | 6.00 |
Dcdc5 |
doublecortin domain containing 5 |
28109 |
0.21 |
chr7_96212598_96213706 | 6.00 |
Tenm4 |
teneurin transmembrane protein 4 |
1481 |
0.42 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.5 | 38.6 | GO:0097011 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) |
4.7 | 14.2 | GO:0003358 | noradrenergic neuron development(GO:0003358) |
4.5 | 13.6 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
4.4 | 13.1 | GO:0003357 | noradrenergic neuron differentiation(GO:0003357) |
4.2 | 12.7 | GO:0021912 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) |
4.2 | 12.7 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
4.1 | 12.2 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
3.7 | 11.0 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
3.6 | 10.8 | GO:1990034 | calcium ion export from cell(GO:1990034) |
3.5 | 10.6 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
3.5 | 10.4 | GO:0071492 | cellular response to UV-A(GO:0071492) |
3.4 | 20.6 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
3.4 | 10.1 | GO:0060594 | mammary gland specification(GO:0060594) |
3.3 | 13.2 | GO:0061743 | motor learning(GO:0061743) |
3.3 | 16.4 | GO:0098596 | vocal learning(GO:0042297) imitative learning(GO:0098596) learned vocalization behavior or vocal learning(GO:0098598) |
3.2 | 19.1 | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
3.2 | 9.5 | GO:0061092 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
3.2 | 9.5 | GO:2000111 | positive regulation of macrophage apoptotic process(GO:2000111) |
3.0 | 9.0 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
3.0 | 8.9 | GO:0061153 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
3.0 | 3.0 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
3.0 | 3.0 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) |
2.9 | 8.8 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
2.9 | 5.8 | GO:0003347 | epicardial cell to mesenchymal cell transition(GO:0003347) |
2.9 | 8.7 | GO:2000302 | positive regulation of synaptic vesicle exocytosis(GO:2000302) |
2.8 | 13.9 | GO:0090383 | phagosome acidification(GO:0090383) |
2.7 | 8.2 | GO:0072318 | clathrin coat disassembly(GO:0072318) |
2.7 | 8.0 | GO:0097112 | gamma-aminobutyric acid receptor clustering(GO:0097112) |
2.5 | 12.7 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
2.5 | 7.5 | GO:0061642 | chemoattraction of axon(GO:0061642) |
2.5 | 7.5 | GO:0061669 | spontaneous neurotransmitter secretion(GO:0061669) spontaneous synaptic transmission(GO:0098814) |
2.4 | 19.2 | GO:0071420 | cellular response to histamine(GO:0071420) |
2.4 | 4.7 | GO:1904684 | negative regulation of metalloendopeptidase activity(GO:1904684) negative regulation of metallopeptidase activity(GO:1905049) |
2.4 | 11.8 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
2.3 | 6.9 | GO:0014053 | negative regulation of gamma-aminobutyric acid secretion(GO:0014053) |
2.3 | 6.8 | GO:1904220 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
2.2 | 6.7 | GO:0086045 | membrane depolarization during AV node cell action potential(GO:0086045) |
2.2 | 6.5 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
2.2 | 6.5 | GO:1902513 | regulation of organelle transport along microtubule(GO:1902513) |
2.1 | 10.7 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
2.1 | 6.4 | GO:0070649 | formin-nucleated actin cable assembly(GO:0070649) |
2.1 | 4.2 | GO:0061031 | endodermal digestive tract morphogenesis(GO:0061031) |
2.1 | 6.2 | GO:0072092 | ureteric bud invasion(GO:0072092) |
2.1 | 10.3 | GO:0021764 | amygdala development(GO:0021764) |
2.1 | 12.3 | GO:0021830 | interneuron migration from the subpallium to the cortex(GO:0021830) |
2.0 | 12.1 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) |
2.0 | 8.1 | GO:1903977 | positive regulation of glial cell migration(GO:1903977) |
2.0 | 10.0 | GO:0003192 | mitral valve formation(GO:0003192) |
2.0 | 12.0 | GO:0046958 | nonassociative learning(GO:0046958) |
2.0 | 7.9 | GO:0046499 | S-adenosylmethioninamine metabolic process(GO:0046499) |
2.0 | 5.9 | GO:0035106 | operant conditioning(GO:0035106) |
2.0 | 5.9 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
1.9 | 5.8 | GO:0060279 | positive regulation of ovulation(GO:0060279) |
1.9 | 11.5 | GO:0032049 | cardiolipin biosynthetic process(GO:0032049) |
1.8 | 11.0 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
1.8 | 1.8 | GO:0097151 | positive regulation of inhibitory postsynaptic potential(GO:0097151) |
1.8 | 3.5 | GO:1902608 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
1.8 | 5.3 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
1.8 | 8.8 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
1.7 | 5.2 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
1.7 | 5.2 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
1.7 | 7.0 | GO:0090427 | activation of meiosis(GO:0090427) |
1.7 | 10.4 | GO:0035881 | amacrine cell differentiation(GO:0035881) |
1.7 | 6.8 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
1.7 | 8.3 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
1.7 | 5.0 | GO:0098910 | regulation of atrial cardiac muscle cell action potential(GO:0098910) |
1.6 | 4.9 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
1.6 | 4.8 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
1.6 | 4.7 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
1.6 | 11.0 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
1.6 | 4.7 | GO:0043308 | eosinophil activation involved in immune response(GO:0002278) eosinophil mediated immunity(GO:0002447) eosinophil degranulation(GO:0043308) |
1.5 | 4.6 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
1.5 | 4.6 | GO:2000019 | negative regulation of male gonad development(GO:2000019) |
1.5 | 4.6 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
1.5 | 1.5 | GO:0060166 | olfactory pit development(GO:0060166) |
1.5 | 7.6 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
1.5 | 3.0 | GO:0007258 | JUN phosphorylation(GO:0007258) |
1.5 | 7.5 | GO:0016198 | axon choice point recognition(GO:0016198) |
1.5 | 6.0 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
1.5 | 11.9 | GO:0044387 | negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
1.5 | 4.4 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
1.5 | 4.4 | GO:1902534 | single-organism membrane invagination(GO:1902534) |
1.5 | 5.9 | GO:0021615 | glossopharyngeal nerve morphogenesis(GO:0021615) |
1.5 | 1.5 | GO:0021550 | medulla oblongata development(GO:0021550) |
1.4 | 7.2 | GO:2000618 | regulation of histone H4-K16 acetylation(GO:2000618) |
1.4 | 1.4 | GO:0014028 | notochord formation(GO:0014028) |
1.4 | 5.6 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
1.4 | 1.4 | GO:0090500 | heart valve formation(GO:0003188) endocardial cushion to mesenchymal transition(GO:0090500) |
1.4 | 2.8 | GO:1901420 | negative regulation of response to alcohol(GO:1901420) |
1.4 | 2.8 | GO:2000599 | regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
1.4 | 4.2 | GO:0055099 | response to high density lipoprotein particle(GO:0055099) |
1.4 | 5.5 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
1.4 | 2.8 | GO:0003253 | cardiac neural crest cell migration involved in outflow tract morphogenesis(GO:0003253) |
1.4 | 8.3 | GO:0060973 | cell migration involved in heart development(GO:0060973) |
1.4 | 13.7 | GO:0034331 | cell junction maintenance(GO:0034331) |
1.4 | 6.8 | GO:0042940 | D-amino acid transport(GO:0042940) |
1.4 | 1.4 | GO:0060160 | negative regulation of dopamine receptor signaling pathway(GO:0060160) |
1.4 | 4.1 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
1.3 | 4.0 | GO:0021603 | cranial nerve formation(GO:0021603) |
1.3 | 5.4 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
1.3 | 4.0 | GO:2000211 | regulation of glutamate metabolic process(GO:2000211) |
1.3 | 5.3 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
1.3 | 5.2 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
1.3 | 7.8 | GO:1903961 | positive regulation of anion transmembrane transport(GO:1903961) |
1.3 | 2.6 | GO:0007191 | adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
1.3 | 7.8 | GO:1904424 | regulation of GTP binding(GO:1904424) |
1.3 | 16.8 | GO:0021681 | cerebellar granular layer development(GO:0021681) |
1.3 | 3.8 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
1.3 | 1.3 | GO:0090135 | actin filament branching(GO:0090135) |
1.3 | 2.5 | GO:0051794 | regulation of catagen(GO:0051794) |
1.3 | 10.1 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
1.2 | 5.0 | GO:0042661 | regulation of mesodermal cell fate specification(GO:0042661) |
1.2 | 2.5 | GO:1901844 | regulation of cell communication by electrical coupling involved in cardiac conduction(GO:1901844) |
1.2 | 2.5 | GO:0051365 | cellular response to potassium ion starvation(GO:0051365) |
1.2 | 1.2 | GO:1903441 | protein localization to ciliary membrane(GO:1903441) |
1.2 | 2.4 | GO:1903984 | positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
1.2 | 9.7 | GO:0048671 | negative regulation of collateral sprouting(GO:0048671) |
1.2 | 9.7 | GO:0097120 | receptor localization to synapse(GO:0097120) |
1.2 | 6.0 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
1.2 | 8.3 | GO:0045199 | maintenance of epithelial cell apical/basal polarity(GO:0045199) |
1.2 | 2.4 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
1.2 | 5.9 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
1.2 | 7.0 | GO:0042473 | outer ear morphogenesis(GO:0042473) |
1.2 | 2.3 | GO:0008355 | olfactory learning(GO:0008355) |
1.2 | 2.3 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
1.2 | 2.3 | GO:0001698 | gastrin-induced gastric acid secretion(GO:0001698) |
1.1 | 6.9 | GO:0035989 | tendon development(GO:0035989) |
1.1 | 1.1 | GO:0072338 | creatinine metabolic process(GO:0046449) cellular lactam metabolic process(GO:0072338) |
1.1 | 26.3 | GO:0001964 | startle response(GO:0001964) |
1.1 | 3.4 | GO:1904058 | positive regulation of sensory perception of pain(GO:1904058) |
1.1 | 10.3 | GO:0021756 | striatum development(GO:0021756) |
1.1 | 1.1 | GO:0019065 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
1.1 | 4.5 | GO:1903626 | positive regulation of apoptotic DNA fragmentation(GO:1902512) positive regulation of DNA catabolic process(GO:1903626) |
1.1 | 2.2 | GO:1990123 | L-glutamate(1-) import into cell(GO:1903802) L-glutamate import into cell(GO:1990123) |
1.1 | 2.2 | GO:0061366 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
1.1 | 3.3 | GO:0098903 | regulation of membrane repolarization during action potential(GO:0098903) |
1.1 | 18.8 | GO:0050650 | chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
1.1 | 2.2 | GO:0071873 | response to norepinephrine(GO:0071873) |
1.1 | 12.1 | GO:0060384 | innervation(GO:0060384) |
1.1 | 8.8 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
1.1 | 4.4 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
1.1 | 3.3 | GO:2000118 | regulation of sodium-dependent phosphate transport(GO:2000118) |
1.1 | 2.2 | GO:0001927 | exocyst assembly(GO:0001927) |
1.1 | 6.5 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
1.1 | 3.2 | GO:1902109 | negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
1.1 | 3.2 | GO:0015770 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
1.1 | 14.0 | GO:0051703 | social behavior(GO:0035176) intraspecies interaction between organisms(GO:0051703) |
1.1 | 3.2 | GO:0030070 | insulin processing(GO:0030070) |
1.1 | 7.5 | GO:0099515 | actin filament-based transport(GO:0099515) |
1.1 | 5.3 | GO:1904587 | glycoprotein ERAD pathway(GO:0097466) response to glycoprotein(GO:1904587) |
1.1 | 7.4 | GO:0060601 | lateral sprouting from an epithelium(GO:0060601) |
1.1 | 12.6 | GO:0048268 | clathrin coat assembly(GO:0048268) |
1.1 | 6.3 | GO:0021511 | spinal cord patterning(GO:0021511) |
1.0 | 4.2 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
1.0 | 6.3 | GO:1900452 | regulation of long term synaptic depression(GO:1900452) |
1.0 | 4.2 | GO:0018211 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
1.0 | 4.2 | GO:0042713 | sperm ejaculation(GO:0042713) |
1.0 | 2.1 | GO:2000381 | negative regulation of mesoderm development(GO:2000381) |
1.0 | 1.0 | GO:0070346 | positive regulation of fat cell proliferation(GO:0070346) |
1.0 | 3.1 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
1.0 | 2.1 | GO:0097091 | synaptic vesicle clustering(GO:0097091) |
1.0 | 4.1 | GO:0008090 | retrograde axonal transport(GO:0008090) |
1.0 | 3.1 | GO:0006868 | glutamine transport(GO:0006868) |
1.0 | 5.2 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
1.0 | 3.1 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
1.0 | 5.1 | GO:0061003 | positive regulation of dendritic spine morphogenesis(GO:0061003) |
1.0 | 5.1 | GO:0032229 | negative regulation of synaptic transmission, GABAergic(GO:0032229) |
1.0 | 1.0 | GO:0000320 | re-entry into mitotic cell cycle(GO:0000320) |
1.0 | 8.1 | GO:0099625 | regulation of ventricular cardiac muscle cell membrane repolarization(GO:0060307) ventricular cardiac muscle cell membrane repolarization(GO:0099625) |
1.0 | 4.0 | GO:0071321 | cellular response to cGMP(GO:0071321) |
1.0 | 2.0 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
1.0 | 3.0 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
1.0 | 16.8 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
1.0 | 3.0 | GO:0021778 | oligodendrocyte cell fate specification(GO:0021778) oligodendrocyte cell fate commitment(GO:0021779) glial cell fate specification(GO:0021780) |
1.0 | 15.8 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
1.0 | 3.0 | GO:0097503 | sialylation(GO:0097503) |
1.0 | 2.0 | GO:1905154 | negative regulation of membrane invagination(GO:1905154) |
1.0 | 2.0 | GO:0007386 | compartment pattern specification(GO:0007386) |
1.0 | 3.9 | GO:0035934 | corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
1.0 | 13.4 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
0.9 | 15.1 | GO:0095500 | acetylcholine receptor signaling pathway(GO:0095500) postsynaptic signal transduction(GO:0098926) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
0.9 | 0.9 | GO:0072235 | distal convoluted tubule development(GO:0072025) DCT cell differentiation(GO:0072069) metanephric distal convoluted tubule development(GO:0072221) metanephric distal tubule development(GO:0072235) metanephric DCT cell differentiation(GO:0072240) mesenchymal stem cell maintenance involved in metanephric nephron morphogenesis(GO:0072309) |
0.9 | 15.1 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.9 | 0.9 | GO:0014029 | neural crest formation(GO:0014029) |
0.9 | 4.7 | GO:2001023 | regulation of response to drug(GO:2001023) |
0.9 | 45.0 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.9 | 10.3 | GO:0008038 | neuron recognition(GO:0008038) |
0.9 | 2.8 | GO:1900738 | positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
0.9 | 2.8 | GO:0034628 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
0.9 | 3.7 | GO:0003100 | regulation of systemic arterial blood pressure by endothelin(GO:0003100) |
0.9 | 0.9 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.9 | 4.6 | GO:0060579 | ventral spinal cord interneuron fate commitment(GO:0060579) cell fate commitment involved in pattern specification(GO:0060581) |
0.9 | 3.7 | GO:0051610 | negative regulation of neurotransmitter uptake(GO:0051581) serotonin uptake(GO:0051610) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
0.9 | 2.8 | GO:0086015 | SA node cell action potential(GO:0086015) SA node cell to atrial cardiac muscle cell signalling(GO:0086018) SA node cell to atrial cardiac muscle cell communication(GO:0086070) |
0.9 | 4.6 | GO:0060087 | relaxation of vascular smooth muscle(GO:0060087) |
0.9 | 12.8 | GO:0010842 | retina layer formation(GO:0010842) |
0.9 | 6.4 | GO:0032308 | positive regulation of prostaglandin secretion(GO:0032308) |
0.9 | 0.9 | GO:0097476 | motor neuron migration(GO:0097475) spinal cord motor neuron migration(GO:0097476) |
0.9 | 3.6 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.9 | 4.5 | GO:0018230 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.9 | 1.8 | GO:0042322 | negative regulation of circadian sleep/wake cycle, REM sleep(GO:0042322) |
0.9 | 1.8 | GO:0021524 | visceral motor neuron differentiation(GO:0021524) |
0.9 | 3.6 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
0.9 | 1.8 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
0.9 | 2.7 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.9 | 3.6 | GO:0014051 | gamma-aminobutyric acid secretion(GO:0014051) |
0.9 | 0.9 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
0.9 | 2.7 | GO:0023041 | neuronal signal transduction(GO:0023041) |
0.9 | 2.7 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
0.9 | 0.9 | GO:1904154 | positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
0.9 | 6.2 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.9 | 5.3 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.9 | 2.6 | GO:0021523 | somatic motor neuron differentiation(GO:0021523) |
0.9 | 9.5 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
0.9 | 1.7 | GO:0014022 | neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
0.9 | 0.9 | GO:0060923 | cardiac muscle cell fate commitment(GO:0060923) |
0.9 | 6.0 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
0.9 | 10.3 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.9 | 2.6 | GO:2000686 | regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
0.9 | 1.7 | GO:1902455 | negative regulation of stem cell population maintenance(GO:1902455) |
0.8 | 0.8 | GO:0048936 | peripheral nervous system neuron axonogenesis(GO:0048936) |
0.8 | 10.1 | GO:0090036 | regulation of protein kinase C signaling(GO:0090036) |
0.8 | 3.3 | GO:0038030 | non-canonical Wnt signaling pathway via MAPK cascade(GO:0038030) |
0.8 | 7.4 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.8 | 4.1 | GO:0015884 | folic acid transport(GO:0015884) |
0.8 | 2.5 | GO:0030167 | proteoglycan catabolic process(GO:0030167) |
0.8 | 2.5 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
0.8 | 3.3 | GO:0016103 | diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
0.8 | 1.6 | GO:0021986 | epithalamus development(GO:0021538) habenula development(GO:0021986) |
0.8 | 1.6 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.8 | 0.8 | GO:0002018 | renin-angiotensin regulation of aldosterone production(GO:0002018) |
0.8 | 1.6 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
0.8 | 3.9 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.8 | 0.8 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
0.8 | 3.1 | GO:0006538 | glutamate catabolic process(GO:0006538) |
0.8 | 9.4 | GO:0097237 | cellular response to toxic substance(GO:0097237) |
0.8 | 3.1 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
0.8 | 2.3 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.8 | 13.9 | GO:0007628 | adult walking behavior(GO:0007628) walking behavior(GO:0090659) |
0.8 | 2.3 | GO:0015803 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.8 | 1.5 | GO:0045759 | negative regulation of action potential(GO:0045759) |
0.8 | 5.3 | GO:0021859 | pyramidal neuron differentiation(GO:0021859) |
0.8 | 1.5 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.8 | 5.3 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) |
0.8 | 2.3 | GO:0010796 | regulation of multivesicular body size(GO:0010796) |
0.8 | 3.0 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.8 | 1.5 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.8 | 3.0 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
0.7 | 2.2 | GO:0046882 | negative regulation of follicle-stimulating hormone secretion(GO:0046882) |
0.7 | 3.0 | GO:2000535 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
0.7 | 3.7 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
0.7 | 3.7 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.7 | 2.2 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
0.7 | 1.5 | GO:0045607 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.7 | 2.2 | GO:0052405 | negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
0.7 | 13.9 | GO:0030224 | monocyte differentiation(GO:0030224) |
0.7 | 3.7 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
0.7 | 2.2 | GO:0050805 | negative regulation of synaptic transmission(GO:0050805) |
0.7 | 4.3 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.7 | 2.2 | GO:0060221 | retinal rod cell differentiation(GO:0060221) |
0.7 | 1.4 | GO:1903416 | response to glycoside(GO:1903416) |
0.7 | 22.8 | GO:0007019 | microtubule depolymerization(GO:0007019) |
0.7 | 4.3 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
0.7 | 2.1 | GO:0061624 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
0.7 | 2.1 | GO:2000546 | positive regulation of cell chemotaxis to fibroblast growth factor(GO:1904849) positive regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000546) |
0.7 | 2.1 | GO:1902564 | negative regulation of neutrophil activation(GO:1902564) |
0.7 | 42.6 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.7 | 0.7 | GO:0021943 | formation of radial glial scaffolds(GO:0021943) |
0.7 | 0.7 | GO:0042421 | norepinephrine biosynthetic process(GO:0042421) |
0.7 | 1.4 | GO:1903596 | regulation of gap junction assembly(GO:1903596) |
0.7 | 4.8 | GO:0006108 | malate metabolic process(GO:0006108) |
0.7 | 4.8 | GO:0019368 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.7 | 9.6 | GO:0061462 | protein localization to lysosome(GO:0061462) |
0.7 | 2.0 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
0.7 | 2.0 | GO:0002930 | trabecular meshwork development(GO:0002930) |
0.7 | 1.4 | GO:0032097 | positive regulation of response to food(GO:0032097) positive regulation of appetite(GO:0032100) |
0.7 | 0.7 | GO:0038171 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
0.7 | 1.3 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
0.7 | 2.7 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
0.7 | 6.0 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.7 | 4.0 | GO:0035878 | nail development(GO:0035878) |
0.7 | 0.7 | GO:0060174 | limb bud formation(GO:0060174) |
0.7 | 0.7 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
0.7 | 2.0 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
0.7 | 0.7 | GO:0007412 | axon target recognition(GO:0007412) |
0.6 | 2.6 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
0.6 | 7.1 | GO:0072498 | embryonic skeletal joint development(GO:0072498) |
0.6 | 7.0 | GO:1990403 | embryonic brain development(GO:1990403) |
0.6 | 1.9 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
0.6 | 0.6 | GO:0090027 | negative regulation of monocyte chemotaxis(GO:0090027) |
0.6 | 1.9 | GO:0045112 | integrin biosynthetic process(GO:0045112) regulation of integrin biosynthetic process(GO:0045113) |
0.6 | 0.6 | GO:1900825 | regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900825) |
0.6 | 3.8 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
0.6 | 2.5 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.6 | 15.2 | GO:0019228 | neuronal action potential(GO:0019228) |
0.6 | 0.6 | GO:0038095 | Fc-epsilon receptor signaling pathway(GO:0038095) |
0.6 | 3.8 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.6 | 1.2 | GO:0070562 | regulation of vitamin D receptor signaling pathway(GO:0070562) |
0.6 | 1.9 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.6 | 0.6 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
0.6 | 1.8 | GO:0032383 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
0.6 | 1.2 | GO:0060916 | mesenchymal cell proliferation involved in lung development(GO:0060916) |
0.6 | 1.8 | GO:0060839 | endothelial cell fate commitment(GO:0060839) |
0.6 | 8.5 | GO:0032012 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.6 | 4.8 | GO:2000671 | regulation of motor neuron apoptotic process(GO:2000671) |
0.6 | 3.0 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.6 | 3.0 | GO:0043268 | positive regulation of potassium ion transport(GO:0043268) |
0.6 | 4.8 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.6 | 6.6 | GO:0007202 | activation of phospholipase C activity(GO:0007202) |
0.6 | 0.6 | GO:0035262 | gonad morphogenesis(GO:0035262) |
0.6 | 1.8 | GO:0060750 | epithelial cell proliferation involved in mammary gland duct elongation(GO:0060750) |
0.6 | 2.9 | GO:0090244 | Wnt signaling pathway involved in somitogenesis(GO:0090244) |
0.6 | 1.2 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
0.6 | 0.6 | GO:1904746 | negative regulation of apoptotic process involved in development(GO:1904746) |
0.6 | 6.4 | GO:0036065 | fucosylation(GO:0036065) |
0.6 | 1.2 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
0.6 | 1.2 | GO:0042939 | glutathione transport(GO:0034635) tripeptide transport(GO:0042939) |
0.6 | 1.2 | GO:0007354 | zygotic determination of anterior/posterior axis, embryo(GO:0007354) |
0.6 | 1.7 | GO:0060437 | lung growth(GO:0060437) |
0.6 | 2.3 | GO:0097048 | dendritic cell apoptotic process(GO:0097048) regulation of dendritic cell apoptotic process(GO:2000668) |
0.6 | 1.1 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
0.6 | 4.5 | GO:0061318 | renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
0.6 | 0.6 | GO:0048664 | neuron fate determination(GO:0048664) |
0.6 | 1.7 | GO:0002017 | regulation of blood volume by renal aldosterone(GO:0002017) |
0.6 | 3.9 | GO:0035437 | maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
0.6 | 0.6 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
0.6 | 0.6 | GO:0038109 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
0.6 | 2.2 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.6 | 6.7 | GO:0086010 | membrane depolarization during action potential(GO:0086010) |
0.6 | 1.1 | GO:0032354 | response to follicle-stimulating hormone(GO:0032354) |
0.6 | 1.7 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
0.6 | 2.8 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.6 | 0.6 | GO:0044557 | relaxation of smooth muscle(GO:0044557) |
0.5 | 0.5 | GO:1903279 | regulation of calcium:sodium antiporter activity(GO:1903279) |
0.5 | 0.5 | GO:0035795 | negative regulation of mitochondrial membrane permeability(GO:0035795) |
0.5 | 1.6 | GO:0070782 | phosphatidylserine exposure on apoptotic cell surface(GO:0070782) |
0.5 | 1.1 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
0.5 | 2.1 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.5 | 1.6 | GO:0010847 | regulation of chromatin assembly(GO:0010847) |
0.5 | 1.1 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
0.5 | 0.5 | GO:0097195 | pilomotor reflex(GO:0097195) |
0.5 | 1.6 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.5 | 4.8 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.5 | 4.8 | GO:0035640 | exploration behavior(GO:0035640) |
0.5 | 2.1 | GO:0048311 | mitochondrion distribution(GO:0048311) |
0.5 | 1.6 | GO:0035907 | dorsal aorta development(GO:0035907) dorsal aorta morphogenesis(GO:0035912) |
0.5 | 0.5 | GO:0089700 | protein kinase D signaling(GO:0089700) |
0.5 | 8.9 | GO:0010765 | positive regulation of sodium ion transport(GO:0010765) |
0.5 | 8.9 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
0.5 | 1.0 | GO:0060837 | blood vessel endothelial cell differentiation(GO:0060837) |
0.5 | 2.1 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.5 | 1.6 | GO:0071694 | protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
0.5 | 5.7 | GO:0046855 | inositol phosphate dephosphorylation(GO:0046855) |
0.5 | 14.8 | GO:1902476 | chloride transmembrane transport(GO:1902476) |
0.5 | 1.5 | GO:0042126 | nitrate metabolic process(GO:0042126) |
0.5 | 0.5 | GO:0097252 | oligodendrocyte apoptotic process(GO:0097252) |
0.5 | 2.0 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
0.5 | 5.0 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
0.5 | 1.5 | GO:0006842 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.5 | 1.0 | GO:0051036 | regulation of endosome size(GO:0051036) |
0.5 | 1.5 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
0.5 | 3.9 | GO:0051764 | actin crosslink formation(GO:0051764) |
0.5 | 1.0 | GO:0007403 | glial cell fate determination(GO:0007403) |
0.5 | 3.9 | GO:0098719 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.5 | 6.8 | GO:0001963 | synaptic transmission, dopaminergic(GO:0001963) |
0.5 | 1.0 | GO:0044860 | protein localization to plasma membrane raft(GO:0044860) |
0.5 | 1.9 | GO:0019478 | D-amino acid catabolic process(GO:0019478) |
0.5 | 0.5 | GO:0021593 | rhombomere morphogenesis(GO:0021593) |
0.5 | 0.5 | GO:0072205 | metanephric collecting duct development(GO:0072205) |
0.5 | 1.9 | GO:0051697 | protein delipidation(GO:0051697) |
0.5 | 1.0 | GO:0002767 | immune response-inhibiting cell surface receptor signaling pathway(GO:0002767) |
0.5 | 1.0 | GO:0071672 | negative regulation of smooth muscle cell chemotaxis(GO:0071672) |
0.5 | 1.0 | GO:0021978 | telencephalon regionalization(GO:0021978) |
0.5 | 1.4 | GO:0070459 | prolactin secretion(GO:0070459) |
0.5 | 1.4 | GO:0050427 | 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
0.5 | 0.9 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.5 | 1.9 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
0.5 | 1.4 | GO:0048934 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
0.5 | 3.3 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
0.5 | 4.7 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.5 | 1.9 | GO:0060012 | synaptic transmission, glycinergic(GO:0060012) |
0.5 | 1.9 | GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
0.5 | 1.8 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
0.5 | 0.5 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
0.5 | 0.9 | GO:1901069 | guanosine-containing compound catabolic process(GO:1901069) |
0.5 | 1.8 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
0.5 | 6.8 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.5 | 1.4 | GO:0034239 | regulation of macrophage fusion(GO:0034239) |
0.5 | 1.8 | GO:2000035 | regulation of stem cell division(GO:2000035) |
0.4 | 0.9 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
0.4 | 0.9 | GO:1903261 | regulation of serine phosphorylation of STAT3 protein(GO:1903261) |
0.4 | 5.8 | GO:0007416 | synapse assembly(GO:0007416) |
0.4 | 0.4 | GO:0051081 | membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
0.4 | 1.3 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.4 | 0.4 | GO:2000680 | regulation of rubidium ion transport(GO:2000680) |
0.4 | 1.8 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
0.4 | 0.9 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.4 | 0.4 | GO:1901162 | serotonin biosynthetic process(GO:0042427) primary amino compound biosynthetic process(GO:1901162) |
0.4 | 2.6 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.4 | 0.4 | GO:0060585 | regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
0.4 | 1.3 | GO:2001184 | positive regulation of interleukin-12 secretion(GO:2001184) |
0.4 | 2.2 | GO:0060120 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
0.4 | 3.5 | GO:0060292 | long term synaptic depression(GO:0060292) |
0.4 | 39.5 | GO:0071805 | potassium ion transmembrane transport(GO:0071805) |
0.4 | 0.4 | GO:1904430 | negative regulation of t-circle formation(GO:1904430) |
0.4 | 1.3 | GO:0019747 | regulation of isoprenoid metabolic process(GO:0019747) |
0.4 | 2.6 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
0.4 | 3.0 | GO:1904152 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) regulation of retrograde protein transport, ER to cytosol(GO:1904152) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
0.4 | 0.8 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
0.4 | 2.5 | GO:0051503 | adenine nucleotide transport(GO:0051503) |
0.4 | 1.7 | GO:0030091 | protein repair(GO:0030091) |
0.4 | 2.1 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) |
0.4 | 1.3 | GO:0001504 | neurotransmitter uptake(GO:0001504) |
0.4 | 0.8 | GO:0002424 | T cell mediated immune response to tumor cell(GO:0002424) regulation of T cell mediated immune response to tumor cell(GO:0002840) |
0.4 | 0.4 | GO:0072393 | microtubule anchoring at microtubule organizing center(GO:0072393) |
0.4 | 0.4 | GO:0030908 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
0.4 | 3.3 | GO:0055003 | cardiac myofibril assembly(GO:0055003) |
0.4 | 1.2 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
0.4 | 1.2 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
0.4 | 0.8 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
0.4 | 1.2 | GO:1904293 | negative regulation of ERAD pathway(GO:1904293) |
0.4 | 4.4 | GO:1903861 | regulation of dendrite extension(GO:1903859) positive regulation of dendrite extension(GO:1903861) |
0.4 | 0.8 | GO:0045585 | regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
0.4 | 0.4 | GO:0061043 | regulation of vascular wound healing(GO:0061043) |
0.4 | 1.2 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
0.4 | 1.2 | GO:0032429 | regulation of phospholipase A2 activity(GO:0032429) |
0.4 | 1.2 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
0.4 | 6.3 | GO:0007289 | spermatid nucleus differentiation(GO:0007289) |
0.4 | 1.2 | GO:0072711 | response to hydroxyurea(GO:0072710) cellular response to hydroxyurea(GO:0072711) |
0.4 | 0.8 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
0.4 | 10.2 | GO:0071526 | semaphorin-plexin signaling pathway(GO:0071526) |
0.4 | 2.7 | GO:0061418 | regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061418) |
0.4 | 0.8 | GO:0061724 | lipophagy(GO:0061724) regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
0.4 | 0.8 | GO:0009212 | dTTP biosynthetic process(GO:0006235) pyrimidine deoxyribonucleoside triphosphate biosynthetic process(GO:0009212) dTTP metabolic process(GO:0046075) |
0.4 | 1.9 | GO:0031116 | positive regulation of microtubule polymerization or depolymerization(GO:0031112) positive regulation of microtubule polymerization(GO:0031116) |
0.4 | 2.3 | GO:0060004 | reflex(GO:0060004) |
0.4 | 0.4 | GO:0046146 | tetrahydrobiopterin metabolic process(GO:0046146) |
0.4 | 2.7 | GO:0071364 | cellular response to epidermal growth factor stimulus(GO:0071364) |
0.4 | 1.5 | GO:0072176 | nephric duct development(GO:0072176) nephric duct morphogenesis(GO:0072178) |
0.4 | 3.8 | GO:0061377 | mammary gland alveolus development(GO:0060749) mammary gland lobule development(GO:0061377) |
0.4 | 2.7 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.4 | 0.4 | GO:1900127 | positive regulation of hyaluronan biosynthetic process(GO:1900127) |
0.4 | 0.4 | GO:2000741 | positive regulation of mesenchymal stem cell differentiation(GO:2000741) |
0.4 | 0.7 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
0.4 | 4.8 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.4 | 0.7 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.4 | 0.4 | GO:2000254 | regulation of male germ cell proliferation(GO:2000254) |
0.4 | 0.4 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.4 | 1.1 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.4 | 1.8 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
0.4 | 0.4 | GO:0051665 | membrane raft localization(GO:0051665) |
0.4 | 2.2 | GO:0006105 | succinate metabolic process(GO:0006105) |
0.4 | 4.3 | GO:0042417 | dopamine metabolic process(GO:0042417) |
0.4 | 0.7 | GO:1902514 | regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1902514) |
0.4 | 1.1 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.4 | 0.7 | GO:0002741 | positive regulation of cytokine secretion involved in immune response(GO:0002741) |
0.4 | 1.8 | GO:0042135 | neurotransmitter catabolic process(GO:0042135) |
0.4 | 2.5 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
0.4 | 1.1 | GO:0014042 | positive regulation of neuron maturation(GO:0014042) |
0.4 | 1.4 | GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
0.4 | 4.2 | GO:0048488 | synaptic vesicle endocytosis(GO:0048488) |
0.3 | 3.1 | GO:0021795 | cerebral cortex cell migration(GO:0021795) |
0.3 | 0.7 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
0.3 | 1.0 | GO:0021873 | forebrain neuroblast division(GO:0021873) |
0.3 | 1.4 | GO:0030311 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.3 | 1.0 | GO:0090310 | negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
0.3 | 2.1 | GO:0035726 | common myeloid progenitor cell proliferation(GO:0035726) |
0.3 | 2.1 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.3 | 0.3 | GO:0070212 | protein poly-ADP-ribosylation(GO:0070212) |
0.3 | 3.5 | GO:0031643 | positive regulation of myelination(GO:0031643) |
0.3 | 2.8 | GO:0002084 | protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
0.3 | 1.7 | GO:0009186 | deoxyribonucleoside diphosphate metabolic process(GO:0009186) |
0.3 | 0.7 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.3 | 1.4 | GO:0048505 | regulation of timing of cell differentiation(GO:0048505) |
0.3 | 21.9 | GO:0001764 | neuron migration(GO:0001764) |
0.3 | 0.3 | GO:1900736 | regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900736) |
0.3 | 1.0 | GO:2000847 | negative regulation of steroid hormone secretion(GO:2000832) negative regulation of corticosteroid hormone secretion(GO:2000847) negative regulation of glucocorticoid secretion(GO:2000850) |
0.3 | 9.7 | GO:0050885 | neuromuscular process controlling balance(GO:0050885) |
0.3 | 1.0 | GO:0014824 | artery smooth muscle contraction(GO:0014824) |
0.3 | 2.3 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.3 | 2.7 | GO:0001553 | luteinization(GO:0001553) |
0.3 | 1.3 | GO:0008300 | isoprenoid catabolic process(GO:0008300) |
0.3 | 0.7 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
0.3 | 0.7 | GO:1901873 | regulation of post-translational protein modification(GO:1901873) negative regulation of post-translational protein modification(GO:1901874) |
0.3 | 1.9 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
0.3 | 1.3 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
0.3 | 1.3 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
0.3 | 5.4 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.3 | 1.0 | GO:0051797 | regulation of hair follicle development(GO:0051797) |
0.3 | 0.9 | GO:2000018 | regulation of male gonad development(GO:2000018) |
0.3 | 0.9 | GO:1900227 | positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
0.3 | 0.6 | GO:0051385 | response to mineralocorticoid(GO:0051385) |
0.3 | 0.3 | GO:0003257 | positive regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation(GO:0003257) |
0.3 | 0.3 | GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
0.3 | 0.6 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
0.3 | 0.6 | GO:1900368 | regulation of RNA interference(GO:1900368) |
0.3 | 1.2 | GO:2001166 | regulation of histone H2B ubiquitination(GO:2001166) positive regulation of histone H2B ubiquitination(GO:2001168) |
0.3 | 0.6 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.3 | 0.3 | GO:0021564 | vagus nerve development(GO:0021564) |
0.3 | 0.3 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
0.3 | 0.6 | GO:1902071 | regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
0.3 | 0.6 | GO:0060023 | soft palate development(GO:0060023) |
0.3 | 0.9 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
0.3 | 0.3 | GO:0003097 | renal water transport(GO:0003097) renal water absorption(GO:0070295) |
0.3 | 0.8 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
0.3 | 1.9 | GO:0060347 | heart trabecula formation(GO:0060347) |
0.3 | 1.1 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
0.3 | 0.3 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
0.3 | 1.4 | GO:0015813 | L-glutamate transport(GO:0015813) |
0.3 | 0.3 | GO:0072401 | signal transduction involved in cell cycle checkpoint(GO:0072395) signal transduction involved in DNA integrity checkpoint(GO:0072401) signal transduction involved in DNA damage checkpoint(GO:0072422) |
0.3 | 4.1 | GO:0007340 | acrosome reaction(GO:0007340) |
0.3 | 0.8 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.3 | 2.4 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
0.3 | 1.1 | GO:0042635 | positive regulation of hair cycle(GO:0042635) |
0.3 | 1.9 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.3 | 7.3 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
0.3 | 0.8 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
0.3 | 2.6 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
0.3 | 3.3 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.3 | 0.8 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.3 | 0.8 | GO:0060179 | male mating behavior(GO:0060179) |
0.3 | 0.3 | GO:0014826 | vein smooth muscle contraction(GO:0014826) |
0.3 | 0.8 | GO:2001012 | mesenchymal cell differentiation involved in kidney development(GO:0072161) mesenchymal cell differentiation involved in renal system development(GO:2001012) |
0.3 | 2.0 | GO:0006012 | galactose metabolic process(GO:0006012) |
0.3 | 0.3 | GO:1901857 | positive regulation of cellular respiration(GO:1901857) |
0.3 | 5.0 | GO:0007588 | excretion(GO:0007588) |
0.3 | 1.0 | GO:0048681 | negative regulation of axon regeneration(GO:0048681) |
0.2 | 0.2 | GO:0072199 | mesenchymal cell proliferation involved in ureter development(GO:0072198) regulation of mesenchymal cell proliferation involved in ureter development(GO:0072199) positive regulation of mesenchymal cell proliferation involved in ureter development(GO:2000729) |
0.2 | 1.7 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
0.2 | 0.2 | GO:0048003 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
0.2 | 1.0 | GO:0046125 | pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
0.2 | 1.5 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.2 | 1.5 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.2 | 1.0 | GO:0019853 | L-ascorbic acid biosynthetic process(GO:0019853) |
0.2 | 1.9 | GO:0042984 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
0.2 | 0.9 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
0.2 | 0.2 | GO:0060982 | coronary artery morphogenesis(GO:0060982) |
0.2 | 0.7 | GO:0021940 | positive regulation of cerebellar granule cell precursor proliferation(GO:0021940) |
0.2 | 0.5 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
0.2 | 0.5 | GO:1901387 | positive regulation of voltage-gated calcium channel activity(GO:1901387) |
0.2 | 3.4 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
0.2 | 2.1 | GO:0030575 | nuclear body organization(GO:0030575) |
0.2 | 0.7 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
0.2 | 0.7 | GO:0070427 | nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) |
0.2 | 0.2 | GO:0031587 | positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031587) determination of liver left/right asymmetry(GO:0071910) |
0.2 | 0.7 | GO:0021794 | thalamus development(GO:0021794) |
0.2 | 0.7 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
0.2 | 0.4 | GO:0046101 | hypoxanthine metabolic process(GO:0046100) hypoxanthine biosynthetic process(GO:0046101) |
0.2 | 0.4 | GO:0048069 | eye pigmentation(GO:0048069) |
0.2 | 0.7 | GO:0042161 | lipoprotein modification(GO:0042160) lipoprotein oxidation(GO:0042161) |
0.2 | 2.0 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.2 | 1.8 | GO:0051966 | regulation of synaptic transmission, glutamatergic(GO:0051966) |
0.2 | 0.4 | GO:0043267 | negative regulation of potassium ion transport(GO:0043267) |
0.2 | 0.7 | GO:0072695 | negative regulation of DNA recombination at telomere(GO:0048239) regulation of DNA recombination at telomere(GO:0072695) |
0.2 | 0.4 | GO:0055009 | atrial cardiac muscle tissue development(GO:0003228) atrial cardiac muscle tissue morphogenesis(GO:0055009) |
0.2 | 3.0 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.2 | 2.6 | GO:0042772 | DNA damage response, signal transduction resulting in transcription(GO:0042772) |
0.2 | 0.4 | GO:0061055 | myotome development(GO:0061055) |
0.2 | 0.9 | GO:0035627 | ceramide transport(GO:0035627) |
0.2 | 0.2 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.2 | 0.9 | GO:1901550 | regulation of endothelial cell development(GO:1901550) regulation of establishment of endothelial barrier(GO:1903140) |
0.2 | 0.4 | GO:0045226 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
0.2 | 0.4 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.2 | 0.4 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
0.2 | 0.4 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
0.2 | 1.3 | GO:0000447 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000447) |
0.2 | 1.3 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.2 | 5.6 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.2 | 0.4 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
0.2 | 1.6 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.2 | 6.7 | GO:2000134 | negative regulation of G1/S transition of mitotic cell cycle(GO:2000134) |
0.2 | 2.2 | GO:2000505 | regulation of energy homeostasis(GO:2000505) |
0.2 | 0.4 | GO:0007066 | female meiosis sister chromatid cohesion(GO:0007066) |
0.2 | 0.2 | GO:0032224 | positive regulation of synaptic transmission, cholinergic(GO:0032224) |
0.2 | 0.4 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.2 | 0.4 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.2 | 0.8 | GO:2000009 | negative regulation of protein localization to cell surface(GO:2000009) |
0.2 | 0.8 | GO:0070126 | mitochondrial translational termination(GO:0070126) |
0.2 | 0.6 | GO:0009256 | 10-formyltetrahydrofolate metabolic process(GO:0009256) |
0.2 | 0.6 | GO:0031086 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.2 | 0.2 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
0.2 | 0.4 | GO:0070375 | ERK5 cascade(GO:0070375) |
0.2 | 0.8 | GO:0070977 | ossification involved in bone maturation(GO:0043931) bone maturation(GO:0070977) |
0.2 | 0.8 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
0.2 | 0.4 | GO:0042231 | interleukin-13 biosynthetic process(GO:0042231) |
0.2 | 0.2 | GO:0071288 | cellular response to mercury ion(GO:0071288) |
0.2 | 1.5 | GO:0042474 | middle ear morphogenesis(GO:0042474) |
0.2 | 1.9 | GO:0044804 | nucleophagy(GO:0044804) |
0.2 | 2.0 | GO:0030539 | male genitalia development(GO:0030539) |
0.2 | 0.5 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.2 | 0.4 | GO:0097694 | establishment of RNA localization to telomere(GO:0097694) |
0.2 | 2.1 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
0.2 | 0.9 | GO:0015824 | proline transport(GO:0015824) |
0.2 | 2.1 | GO:0043248 | proteasome assembly(GO:0043248) |
0.2 | 0.3 | GO:0050955 | thermoception(GO:0050955) |
0.2 | 0.7 | GO:0033227 | dsRNA transport(GO:0033227) |
0.2 | 0.7 | GO:0060467 | negative regulation of fertilization(GO:0060467) |
0.2 | 0.7 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.2 | 0.7 | GO:0046654 | tetrahydrofolate biosynthetic process(GO:0046654) |
0.2 | 3.2 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) |
0.2 | 2.4 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
0.2 | 0.2 | GO:0033122 | negative regulation of purine nucleotide catabolic process(GO:0033122) |
0.2 | 0.5 | GO:0034093 | positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
0.2 | 1.8 | GO:0010165 | response to X-ray(GO:0010165) |
0.2 | 1.2 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.2 | 0.8 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
0.2 | 0.5 | GO:0021846 | cell proliferation in forebrain(GO:0021846) |
0.2 | 1.0 | GO:0090103 | cochlea morphogenesis(GO:0090103) |
0.2 | 0.5 | GO:2000325 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
0.2 | 0.3 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
0.2 | 0.3 | GO:0050655 | dermatan sulfate metabolic process(GO:0030205) dermatan sulfate proteoglycan metabolic process(GO:0050655) |
0.2 | 1.6 | GO:0046348 | amino sugar catabolic process(GO:0046348) |
0.2 | 0.2 | GO:0072217 | negative regulation of metanephros development(GO:0072217) |
0.2 | 0.2 | GO:0021895 | cerebral cortex neuron differentiation(GO:0021895) |
0.2 | 0.3 | GO:0043366 | beta selection(GO:0043366) |
0.2 | 0.8 | GO:0060914 | heart formation(GO:0060914) |
0.2 | 2.4 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
0.2 | 0.6 | GO:0046541 | saliva secretion(GO:0046541) |
0.2 | 1.3 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
0.2 | 1.7 | GO:0051646 | mitochondrion localization(GO:0051646) |
0.2 | 0.2 | GO:0071639 | positive regulation of monocyte chemotactic protein-1 production(GO:0071639) |
0.2 | 0.2 | GO:0043397 | corticotropin-releasing hormone secretion(GO:0043396) regulation of corticotropin-releasing hormone secretion(GO:0043397) positive regulation of corticotropin-releasing hormone secretion(GO:0051466) |
0.2 | 0.3 | GO:1901078 | negative regulation of relaxation of muscle(GO:1901078) |
0.2 | 0.3 | GO:1902047 | polyamine transmembrane transport(GO:1902047) regulation of polyamine transmembrane transport(GO:1902267) |
0.2 | 0.3 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
0.2 | 5.8 | GO:0097485 | neuron projection guidance(GO:0097485) |
0.2 | 0.5 | GO:0010917 | negative regulation of mitochondrial membrane potential(GO:0010917) |
0.2 | 0.2 | GO:0048859 | formation of anatomical boundary(GO:0048859) |
0.1 | 2.1 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
0.1 | 0.6 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
0.1 | 0.7 | GO:0090267 | positive regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090267) |
0.1 | 0.4 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
0.1 | 0.3 | GO:0090158 | endoplasmic reticulum membrane organization(GO:0090158) |
0.1 | 0.1 | GO:0060971 | embryonic heart tube left/right pattern formation(GO:0060971) |
0.1 | 0.9 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.1 | 0.4 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
0.1 | 0.6 | GO:0002318 | myeloid progenitor cell differentiation(GO:0002318) |
0.1 | 0.3 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.1 | 0.3 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
0.1 | 0.3 | GO:0019732 | antifungal humoral response(GO:0019732) |
0.1 | 0.6 | GO:0010820 | positive regulation of T cell chemotaxis(GO:0010820) |
0.1 | 0.3 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.1 | 0.1 | GO:0015842 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) neurotransmitter loading into synaptic vesicle(GO:0098700) |
0.1 | 0.3 | GO:0051324 | meiotic prophase I(GO:0007128) prophase(GO:0051324) meiotic cell cycle phase(GO:0098762) meiosis I cell cycle phase(GO:0098764) |
0.1 | 0.5 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.1 | 0.3 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
0.1 | 0.3 | GO:0070092 | regulation of glucagon secretion(GO:0070092) |
0.1 | 0.3 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.1 | 0.5 | GO:0045579 | positive regulation of B cell differentiation(GO:0045579) |
0.1 | 0.4 | GO:0001806 | type IV hypersensitivity(GO:0001806) |
0.1 | 0.4 | GO:0038003 | opioid receptor signaling pathway(GO:0038003) |
0.1 | 1.2 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.1 | 0.4 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.1 | 7.7 | GO:0006836 | neurotransmitter transport(GO:0006836) |
0.1 | 0.8 | GO:0002052 | positive regulation of neuroblast proliferation(GO:0002052) |
0.1 | 1.0 | GO:0008347 | glial cell migration(GO:0008347) |
0.1 | 0.3 | GO:0006562 | proline catabolic process(GO:0006562) |
0.1 | 0.1 | GO:0010578 | regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
0.1 | 0.4 | GO:0046689 | response to mercury ion(GO:0046689) |
0.1 | 0.5 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
0.1 | 0.1 | GO:0033030 | negative regulation of neutrophil apoptotic process(GO:0033030) |
0.1 | 0.1 | GO:0071673 | positive regulation of smooth muscle cell chemotaxis(GO:0071673) |
0.1 | 0.2 | GO:0006382 | adenosine to inosine editing(GO:0006382) |
0.1 | 0.4 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.1 | 0.4 | GO:0032202 | telomere assembly(GO:0032202) |
0.1 | 0.4 | GO:0046618 | drug export(GO:0046618) |
0.1 | 1.6 | GO:0032743 | positive regulation of interleukin-2 production(GO:0032743) |
0.1 | 0.2 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
0.1 | 0.8 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.1 | 0.1 | GO:0060825 | fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060825) regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000313) |
0.1 | 0.7 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.1 | 0.1 | GO:0097212 | lysosomal membrane organization(GO:0097212) |
0.1 | 0.5 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.1 | 0.3 | GO:0042723 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.1 | 0.3 | GO:0043046 | DNA methylation involved in gamete generation(GO:0043046) |
0.1 | 0.1 | GO:0006114 | glycerol biosynthetic process(GO:0006114) |
0.1 | 0.5 | GO:0021854 | hypothalamus development(GO:0021854) |
0.1 | 1.5 | GO:0051647 | nucleus localization(GO:0051647) |
0.1 | 0.2 | GO:0010887 | negative regulation of cholesterol storage(GO:0010887) |
0.1 | 0.2 | GO:0001710 | mesodermal cell fate commitment(GO:0001710) |
0.1 | 0.1 | GO:2000391 | regulation of neutrophil extravasation(GO:2000389) positive regulation of neutrophil extravasation(GO:2000391) |
0.1 | 0.4 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.1 | 0.2 | GO:0060335 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
0.1 | 2.6 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.1 | 0.1 | GO:0032831 | positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032831) |
0.1 | 0.3 | GO:0001835 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
0.1 | 0.1 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
0.1 | 0.1 | GO:2000410 | thymocyte migration(GO:0072679) regulation of thymocyte migration(GO:2000410) positive regulation of thymocyte migration(GO:2000412) |
0.1 | 0.2 | GO:0060754 | positive regulation of mast cell chemotaxis(GO:0060754) |
0.1 | 0.5 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
0.1 | 0.3 | GO:0021884 | forebrain neuron development(GO:0021884) |
0.1 | 0.2 | GO:0045054 | constitutive secretory pathway(GO:0045054) |
0.1 | 0.3 | GO:0000350 | generation of catalytic spliceosome for second transesterification step(GO:0000350) |
0.1 | 0.9 | GO:0032688 | negative regulation of interferon-beta production(GO:0032688) |
0.1 | 0.3 | GO:0071494 | cellular response to UV-C(GO:0071494) |
0.1 | 0.1 | GO:0045080 | positive regulation of chemokine biosynthetic process(GO:0045080) |
0.1 | 0.9 | GO:0019885 | antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
0.1 | 0.8 | GO:0043949 | regulation of cAMP-mediated signaling(GO:0043949) |
0.1 | 0.6 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
0.1 | 0.4 | GO:0070528 | protein kinase C signaling(GO:0070528) |
0.1 | 0.3 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) |
0.1 | 0.1 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
0.1 | 0.1 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
0.1 | 0.1 | GO:0014050 | negative regulation of glutamate secretion(GO:0014050) |
0.1 | 0.1 | GO:0048570 | notochord morphogenesis(GO:0048570) |
0.1 | 0.4 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
0.1 | 0.2 | GO:0035747 | natural killer cell chemotaxis(GO:0035747) regulation of natural killer cell chemotaxis(GO:2000501) positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.1 | 0.3 | GO:0036123 | histone H3-K9 dimethylation(GO:0036123) |
0.1 | 0.2 | GO:0035425 | autocrine signaling(GO:0035425) |
0.1 | 0.3 | GO:0042249 | establishment of planar polarity of embryonic epithelium(GO:0042249) |
0.1 | 0.1 | GO:0008078 | mesodermal cell migration(GO:0008078) |
0.1 | 2.9 | GO:0001578 | microtubule bundle formation(GO:0001578) |
0.1 | 0.4 | GO:0071918 | urea transmembrane transport(GO:0071918) |
0.1 | 0.1 | GO:2000402 | negative regulation of lymphocyte migration(GO:2000402) |
0.1 | 0.2 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.1 | 1.2 | GO:0045671 | negative regulation of osteoclast differentiation(GO:0045671) |
0.1 | 0.2 | GO:0035633 | maintenance of blood-brain barrier(GO:0035633) |
0.1 | 0.4 | GO:2000484 | positive regulation of interleukin-8 secretion(GO:2000484) |
0.1 | 0.1 | GO:0051305 | chromosome movement towards spindle pole(GO:0051305) |
0.1 | 0.3 | GO:0002713 | negative regulation of B cell mediated immunity(GO:0002713) negative regulation of immunoglobulin mediated immune response(GO:0002890) |
0.1 | 0.2 | GO:0051547 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
0.1 | 0.2 | GO:0022615 | protein to membrane docking(GO:0022615) |
0.1 | 0.6 | GO:0071281 | cellular response to iron ion(GO:0071281) |
0.1 | 0.3 | GO:0009624 | response to nematode(GO:0009624) |
0.1 | 0.2 | GO:0070244 | negative regulation of thymocyte apoptotic process(GO:0070244) |
0.1 | 0.3 | GO:0000479 | endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000479) |
0.1 | 1.7 | GO:0034605 | cellular response to heat(GO:0034605) |
0.1 | 0.2 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.1 | 0.1 | GO:0070172 | positive regulation of tooth mineralization(GO:0070172) |
0.1 | 0.1 | GO:1902414 | protein localization to cell junction(GO:1902414) |
0.1 | 0.1 | GO:0071655 | macrophage colony-stimulating factor production(GO:0036301) granulocyte colony-stimulating factor production(GO:0071611) regulation of granulocyte colony-stimulating factor production(GO:0071655) regulation of macrophage colony-stimulating factor production(GO:1901256) |
0.1 | 0.6 | GO:0006071 | glycerol metabolic process(GO:0006071) |
0.1 | 0.3 | GO:1901678 | iron coordination entity transport(GO:1901678) |
0.1 | 0.7 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.1 | 0.2 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.1 | 0.1 | GO:0002277 | myeloid dendritic cell activation involved in immune response(GO:0002277) |
0.1 | 0.2 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.1 | 0.2 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.1 | 0.2 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.1 | 0.4 | GO:0034398 | telomere tethering at nuclear periphery(GO:0034398) |
0.1 | 0.3 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.1 | 1.4 | GO:0072384 | organelle transport along microtubule(GO:0072384) |
0.1 | 0.2 | GO:0018879 | biphenyl metabolic process(GO:0018879) |
0.1 | 0.1 | GO:0031585 | regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031585) |
0.1 | 0.2 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) |
0.1 | 0.1 | GO:0032672 | regulation of interleukin-3 production(GO:0032672) |
0.1 | 0.1 | GO:0090365 | regulation of mRNA modification(GO:0090365) |
0.1 | 0.1 | GO:0010963 | regulation of amino acid import(GO:0010958) regulation of L-arginine import(GO:0010963) |
0.1 | 1.7 | GO:0019835 | cytolysis(GO:0019835) |
0.1 | 0.5 | GO:1904867 | protein localization to nuclear body(GO:1903405) protein localization to Cajal body(GO:1904867) regulation of protein localization to Cajal body(GO:1904869) positive regulation of protein localization to Cajal body(GO:1904871) protein localization to nucleoplasm(GO:1990173) |
0.1 | 0.1 | GO:0000393 | spliceosomal conformational changes to generate catalytic conformation(GO:0000393) |
0.1 | 0.1 | GO:0070091 | glucagon secretion(GO:0070091) |
0.1 | 0.9 | GO:0006085 | acetyl-CoA biosynthetic process(GO:0006085) |
0.1 | 0.1 | GO:0006059 | hexitol metabolic process(GO:0006059) |
0.1 | 0.1 | GO:0070343 | white fat cell proliferation(GO:0070343) regulation of white fat cell proliferation(GO:0070350) |
0.1 | 0.6 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.1 | 0.2 | GO:0044351 | macropinocytosis(GO:0044351) |
0.1 | 0.2 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.1 | 0.1 | GO:0042494 | detection of bacterial lipoprotein(GO:0042494) |
0.1 | 0.5 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.1 | 0.1 | GO:0060618 | nipple development(GO:0060618) |
0.1 | 0.1 | GO:0042428 | serotonin metabolic process(GO:0042428) |
0.1 | 0.1 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.1 | 0.1 | GO:2000553 | positive regulation of T-helper 2 cell cytokine production(GO:2000553) |
0.1 | 0.3 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.1 | 0.1 | GO:0031296 | B cell costimulation(GO:0031296) |
0.1 | 0.1 | GO:0060460 | left lung development(GO:0060459) left lung morphogenesis(GO:0060460) |
0.1 | 0.4 | GO:0006582 | melanin metabolic process(GO:0006582) |
0.1 | 0.1 | GO:0003157 | endocardium development(GO:0003157) |
0.1 | 0.1 | GO:1903998 | regulation of eating behavior(GO:1903998) |
0.1 | 0.2 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.1 | 0.2 | GO:0035902 | response to immobilization stress(GO:0035902) |
0.1 | 0.3 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
0.1 | 0.3 | GO:0060736 | prostate gland growth(GO:0060736) |
0.1 | 0.1 | GO:0039689 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
0.1 | 0.5 | GO:0032693 | negative regulation of interleukin-10 production(GO:0032693) |
0.1 | 0.1 | GO:1901252 | regulation of intracellular transport of viral material(GO:1901252) |
0.1 | 0.1 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.1 | 0.4 | GO:0031573 | intra-S DNA damage checkpoint(GO:0031573) |
0.0 | 0.2 | GO:0006742 | NADP catabolic process(GO:0006742) |
0.0 | 0.1 | GO:0014046 | dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
0.0 | 0.0 | GO:0009181 | purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
0.0 | 0.2 | GO:0034397 | telomere localization(GO:0034397) |
0.0 | 0.0 | GO:0032048 | cardiolipin metabolic process(GO:0032048) |
0.0 | 2.0 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
0.0 | 0.0 | GO:0019087 | transformation of host cell by virus(GO:0019087) |
0.0 | 0.5 | GO:0048240 | sperm capacitation(GO:0048240) |
0.0 | 0.1 | GO:1904417 | regulation of xenophagy(GO:1904415) positive regulation of xenophagy(GO:1904417) |
0.0 | 0.0 | GO:0060157 | urinary bladder development(GO:0060157) |
0.0 | 0.7 | GO:0006491 | N-glycan processing(GO:0006491) |
0.0 | 0.2 | GO:0034390 | smooth muscle cell apoptotic process(GO:0034390) regulation of smooth muscle cell apoptotic process(GO:0034391) |
0.0 | 0.0 | GO:0070460 | thyroid-stimulating hormone secretion(GO:0070460) |
0.0 | 0.0 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.0 | 0.3 | GO:0060576 | intestinal epithelial cell development(GO:0060576) |
0.0 | 0.1 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
0.0 | 0.0 | GO:0060125 | negative regulation of growth hormone secretion(GO:0060125) |
0.0 | 0.4 | GO:0042407 | cristae formation(GO:0042407) |
0.0 | 0.2 | GO:0051451 | myoblast migration(GO:0051451) |
0.0 | 0.1 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
0.0 | 0.0 | GO:0045356 | positive regulation of interferon-alpha biosynthetic process(GO:0045356) |
0.0 | 0.1 | GO:0048162 | preantral ovarian follicle growth(GO:0001546) multi-layer follicle stage(GO:0048162) |
0.0 | 0.5 | GO:0007271 | synaptic transmission, cholinergic(GO:0007271) |
0.0 | 0.2 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
0.0 | 0.2 | GO:0044766 | multi-organism transport(GO:0044766) viral mRNA export from host cell nucleus(GO:0046784) multi-organism localization(GO:1902579) |
0.0 | 0.1 | GO:0097459 | iron ion import into cell(GO:0097459) |
0.0 | 0.1 | GO:0097501 | stress response to metal ion(GO:0097501) |
0.0 | 3.6 | GO:0019236 | response to pheromone(GO:0019236) |
0.0 | 0.1 | GO:0009128 | purine nucleoside monophosphate catabolic process(GO:0009128) |
0.0 | 0.0 | GO:2001201 | transforming growth factor-beta secretion(GO:0038044) regulation of transforming growth factor-beta secretion(GO:2001201) |
0.0 | 2.9 | GO:0000423 | macromitophagy(GO:0000423) |
0.0 | 0.0 | GO:0042253 | granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0042253) regulation of granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0045423) |
0.0 | 0.0 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.0 | 0.1 | GO:0070858 | negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
0.0 | 0.0 | GO:2000321 | positive regulation of T-helper 17 cell differentiation(GO:2000321) |
0.0 | 0.0 | GO:2001274 | negative regulation of glucose import in response to insulin stimulus(GO:2001274) |
0.0 | 0.0 | GO:1901668 | regulation of superoxide dismutase activity(GO:1901668) |
0.0 | 0.1 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
0.0 | 0.0 | GO:0045409 | negative regulation of interleukin-6 biosynthetic process(GO:0045409) |
0.0 | 0.1 | GO:0032402 | establishment of melanosome localization(GO:0032401) melanosome transport(GO:0032402) |
0.0 | 0.0 | GO:0032304 | negative regulation of icosanoid secretion(GO:0032304) |
0.0 | 0.0 | GO:0060112 | generation of ovulation cycle rhythm(GO:0060112) |
0.0 | 0.1 | GO:0009134 | nucleoside diphosphate catabolic process(GO:0009134) |
0.0 | 0.0 | GO:1900086 | regulation of peptidyl-tyrosine autophosphorylation(GO:1900084) positive regulation of peptidyl-tyrosine autophosphorylation(GO:1900086) |
0.0 | 0.0 | GO:0021936 | regulation of cerebellar granule cell precursor proliferation(GO:0021936) |
0.0 | 0.2 | GO:0003334 | keratinocyte development(GO:0003334) |
0.0 | 0.0 | GO:0009226 | nucleotide-sugar biosynthetic process(GO:0009226) |
0.0 | 0.0 | GO:0046102 | inosine metabolic process(GO:0046102) |
0.0 | 0.1 | GO:0050962 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.0 | 0.0 | GO:0045760 | positive regulation of action potential(GO:0045760) |
0.0 | 0.1 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.0 | 0.0 | GO:0001978 | regulation of systemic arterial blood pressure by carotid sinus baroreceptor feedback(GO:0001978) |
0.0 | 0.1 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.0 | 0.1 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
0.0 | 0.0 | GO:0072367 | regulation of lipid transport by regulation of transcription from RNA polymerase II promoter(GO:0072367) |
0.0 | 0.1 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
0.0 | 0.0 | GO:0015889 | cobalamin transport(GO:0015889) |
0.0 | 0.0 | GO:0032277 | negative regulation of gonadotropin secretion(GO:0032277) |
0.0 | 0.0 | GO:0061309 | cardiac neural crest cell development involved in outflow tract morphogenesis(GO:0061309) |
0.0 | 0.0 | GO:0009629 | response to gravity(GO:0009629) |
0.0 | 0.0 | GO:0097070 | ductus arteriosus closure(GO:0097070) |
0.0 | 0.1 | GO:1900004 | regulation of serine-type endopeptidase activity(GO:1900003) negative regulation of serine-type endopeptidase activity(GO:1900004) regulation of serine-type peptidase activity(GO:1902571) negative regulation of serine-type peptidase activity(GO:1902572) |
0.0 | 0.0 | GO:0035701 | hematopoietic stem cell migration(GO:0035701) |
0.0 | 0.1 | GO:0019532 | oxalate transport(GO:0019532) |
0.0 | 0.1 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.0 | 0.0 | GO:0002727 | natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) |
0.0 | 0.0 | GO:1990168 | protein K29-linked deubiquitination(GO:0035523) protein K33-linked deubiquitination(GO:1990168) |
0.0 | 0.0 | GO:0014835 | myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) |
0.0 | 0.0 | GO:0071799 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.0 | 0.0 | GO:0033007 | negative regulation of mast cell activation involved in immune response(GO:0033007) |
0.0 | 0.1 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
0.0 | 0.1 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.0 | 0.7 | GO:0050912 | detection of chemical stimulus involved in sensory perception of taste(GO:0050912) |
0.0 | 0.0 | GO:0032066 | nucleolus to nucleoplasm transport(GO:0032066) |
0.0 | 0.0 | GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
0.0 | 0.0 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.0 | 0.0 | GO:0030242 | pexophagy(GO:0030242) |
0.0 | 0.5 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
0.0 | 0.0 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.0 | 0.0 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.0 | 0.0 | GO:0071725 | response to triacyl bacterial lipopeptide(GO:0071725) cellular response to triacyl bacterial lipopeptide(GO:0071727) |
0.0 | 0.0 | GO:0043382 | positive regulation of memory T cell differentiation(GO:0043382) |
0.0 | 0.0 | GO:0039530 | MDA-5 signaling pathway(GO:0039530) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.2 | 12.6 | GO:1990812 | growth cone filopodium(GO:1990812) |
2.7 | 8.1 | GO:0072534 | perineuronal net(GO:0072534) |
2.7 | 10.7 | GO:0044308 | axonal spine(GO:0044308) |
2.5 | 2.5 | GO:0044326 | dendritic spine neck(GO:0044326) |
2.5 | 30.0 | GO:0043194 | axon initial segment(GO:0043194) |
2.5 | 7.4 | GO:0097648 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
2.4 | 21.5 | GO:0036128 | CatSper complex(GO:0036128) |
2.2 | 8.8 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
2.2 | 8.7 | GO:0002142 | stereocilia ankle link complex(GO:0002142) |
2.1 | 8.4 | GO:0045298 | tubulin complex(GO:0045298) |
1.9 | 15.4 | GO:0043083 | synaptic cleft(GO:0043083) |
1.9 | 5.7 | GO:0043511 | inhibin complex(GO:0043511) |
1.9 | 54.7 | GO:0048786 | presynaptic active zone(GO:0048786) |
1.9 | 1.9 | GO:0031094 | platelet dense tubular network(GO:0031094) |
1.8 | 32.8 | GO:1902711 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
1.7 | 66.9 | GO:0042734 | presynaptic membrane(GO:0042734) |
1.6 | 14.5 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
1.6 | 9.5 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
1.6 | 9.4 | GO:0031258 | lamellipodium membrane(GO:0031258) |
1.5 | 27.6 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
1.5 | 18.4 | GO:0030673 | axolemma(GO:0030673) |
1.5 | 4.5 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
1.5 | 6.0 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
1.5 | 39.9 | GO:0098878 | ionotropic glutamate receptor complex(GO:0008328) neurotransmitter receptor complex(GO:0098878) |
1.5 | 1.5 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
1.5 | 11.6 | GO:0072687 | meiotic spindle(GO:0072687) |
1.4 | 5.6 | GO:0097425 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
1.3 | 4.0 | GO:0097427 | microtubule bundle(GO:0097427) |
1.3 | 5.2 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
1.2 | 6.2 | GO:0098563 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
1.2 | 7.4 | GO:0016012 | sarcoglycan complex(GO:0016012) |
1.2 | 3.7 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
1.2 | 15.9 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
1.1 | 2.3 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
1.1 | 8.8 | GO:0030314 | junctional membrane complex(GO:0030314) |
1.1 | 3.2 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
1.0 | 4.1 | GO:0016600 | flotillin complex(GO:0016600) |
1.0 | 4.0 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
1.0 | 3.0 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
1.0 | 13.4 | GO:0032590 | dendrite membrane(GO:0032590) |
1.0 | 52.8 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.9 | 1.9 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.9 | 13.3 | GO:0031045 | dense core granule(GO:0031045) |
0.9 | 7.3 | GO:0097449 | astrocyte projection(GO:0097449) |
0.9 | 0.9 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.9 | 12.6 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
0.9 | 2.6 | GO:0032280 | symmetric synapse(GO:0032280) |
0.9 | 6.0 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.8 | 7.5 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.8 | 3.2 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.8 | 4.6 | GO:0001652 | granular component(GO:0001652) |
0.7 | 9.0 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.7 | 1.5 | GO:0043203 | axon hillock(GO:0043203) |
0.7 | 7.4 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.7 | 2.2 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.7 | 2.9 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
0.7 | 2.8 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.7 | 5.5 | GO:0005883 | neurofilament(GO:0005883) |
0.7 | 2.1 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.7 | 3.4 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
0.7 | 2.0 | GO:0005606 | laminin-1 complex(GO:0005606) |
0.7 | 0.7 | GO:0032589 | neuron projection membrane(GO:0032589) |
0.6 | 2.6 | GO:0016942 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
0.6 | 1.9 | GO:0071942 | XPC complex(GO:0071942) |
0.6 | 8.6 | GO:0034704 | calcium channel complex(GO:0034704) |
0.6 | 1.8 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.6 | 2.3 | GO:0033269 | internode region of axon(GO:0033269) |
0.6 | 74.8 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.5 | 1.1 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.5 | 0.5 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.5 | 3.2 | GO:0005915 | zonula adherens(GO:0005915) |
0.5 | 0.5 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.5 | 2.6 | GO:0070695 | FHF complex(GO:0070695) |
0.5 | 4.1 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.5 | 3.0 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.5 | 2.0 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
0.5 | 3.0 | GO:0032584 | growth cone membrane(GO:0032584) |
0.5 | 1.5 | GO:0036194 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.5 | 1.5 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
0.5 | 9.0 | GO:0030904 | retromer complex(GO:0030904) |
0.5 | 64.8 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.5 | 0.9 | GO:1990635 | proximal dendrite(GO:1990635) |
0.5 | 5.5 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.5 | 1.4 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.4 | 0.4 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
0.4 | 0.8 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
0.4 | 1.7 | GO:0070545 | PeBoW complex(GO:0070545) |
0.4 | 1.7 | GO:0097433 | dense body(GO:0097433) |
0.4 | 3.6 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.4 | 0.8 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.4 | 8.3 | GO:0043198 | dendritic shaft(GO:0043198) |
0.4 | 23.0 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.4 | 1.1 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.4 | 1.1 | GO:0043219 | lateral loop(GO:0043219) |
0.4 | 1.5 | GO:0030122 | AP-2 adaptor complex(GO:0030122) |
0.4 | 1.8 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.4 | 0.7 | GO:0033268 | node of Ranvier(GO:0033268) |
0.4 | 2.1 | GO:0071439 | clathrin complex(GO:0071439) |
0.4 | 3.2 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.3 | 1.4 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.3 | 13.0 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.3 | 28.4 | GO:0008021 | synaptic vesicle(GO:0008021) |
0.3 | 0.6 | GO:0033647 | host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) |
0.3 | 2.9 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.3 | 4.8 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.3 | 1.6 | GO:0071547 | piP-body(GO:0071547) |
0.3 | 2.6 | GO:0097542 | ciliary tip(GO:0097542) |
0.3 | 0.3 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.3 | 2.9 | GO:0043196 | varicosity(GO:0043196) |
0.3 | 0.9 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.3 | 2.3 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.3 | 2.5 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.3 | 4.0 | GO:0070382 | exocytic vesicle(GO:0070382) |
0.3 | 0.3 | GO:0035061 | interchromatin granule(GO:0035061) |
0.3 | 2.7 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.3 | 0.8 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.3 | 5.1 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.3 | 1.1 | GO:0034991 | nuclear meiotic cohesin complex(GO:0034991) |
0.3 | 1.3 | GO:0000235 | astral microtubule(GO:0000235) |
0.2 | 11.9 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.2 | 1.7 | GO:0000153 | cytoplasmic ubiquitin ligase complex(GO:0000153) |
0.2 | 0.7 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.2 | 2.1 | GO:0060091 | kinocilium(GO:0060091) |
0.2 | 0.2 | GO:0098573 | intrinsic component of mitochondrial membrane(GO:0098573) |
0.2 | 0.4 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
0.2 | 1.4 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.2 | 1.4 | GO:0070187 | telosome(GO:0070187) |
0.2 | 1.4 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.2 | 0.6 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.2 | 0.8 | GO:0035339 | SPOTS complex(GO:0035339) |
0.2 | 7.3 | GO:0043195 | terminal bouton(GO:0043195) |
0.2 | 0.4 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.2 | 0.7 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
0.2 | 0.5 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.2 | 3.1 | GO:0030057 | desmosome(GO:0030057) |
0.2 | 0.5 | GO:0008275 | gamma-tubulin small complex(GO:0008275) |
0.2 | 0.8 | GO:0042611 | MHC protein complex(GO:0042611) |
0.2 | 1.3 | GO:0032433 | filopodium tip(GO:0032433) |
0.2 | 0.5 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.2 | 1.8 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.2 | 2.3 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.2 | 0.6 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
0.2 | 0.9 | GO:0000445 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.1 | 0.4 | GO:0005726 | perichromatin fibrils(GO:0005726) |
0.1 | 0.1 | GO:0044304 | main axon(GO:0044304) |
0.1 | 1.2 | GO:0005750 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
0.1 | 0.6 | GO:0030478 | actin cap(GO:0030478) |
0.1 | 0.6 | GO:0071546 | pi-body(GO:0071546) |
0.1 | 1.3 | GO:0036156 | inner dynein arm(GO:0036156) |
0.1 | 0.4 | GO:0000802 | transverse filament(GO:0000802) |
0.1 | 3.9 | GO:0030315 | T-tubule(GO:0030315) |
0.1 | 11.4 | GO:0005604 | basement membrane(GO:0005604) |
0.1 | 0.8 | GO:0005766 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.1 | 3.5 | GO:0031941 | filamentous actin(GO:0031941) |
0.1 | 0.1 | GO:0030893 | meiotic cohesin complex(GO:0030893) |
0.1 | 0.5 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.1 | 0.6 | GO:0001674 | female germ cell nucleus(GO:0001674) |
0.1 | 0.3 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
0.1 | 0.4 | GO:0044214 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.1 | 1.2 | GO:0097440 | apical dendrite(GO:0097440) |
0.1 | 1.7 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) |
0.1 | 1.2 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.1 | 0.8 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.1 | 1.8 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.1 | 0.7 | GO:0071437 | invadopodium(GO:0071437) |
0.1 | 1.1 | GO:0005639 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) |
0.1 | 0.2 | GO:0044316 | cone cell pedicle(GO:0044316) |
0.1 | 0.3 | GO:0036396 | MIS complex(GO:0036396) |
0.1 | 0.4 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.1 | 0.7 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.1 | 0.8 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.1 | 6.2 | GO:0005930 | axoneme(GO:0005930) ciliary plasm(GO:0097014) |
0.1 | 1.4 | GO:0001741 | XY body(GO:0001741) |
0.1 | 1.6 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.1 | 2.9 | GO:0030175 | filopodium(GO:0030175) |
0.1 | 0.4 | GO:0005796 | Golgi lumen(GO:0005796) |
0.1 | 0.3 | GO:0033503 | HULC complex(GO:0033503) |
0.1 | 0.4 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.1 | 0.5 | GO:0031983 | vesicle lumen(GO:0031983) |
0.1 | 2.8 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.1 | 0.1 | GO:0044453 | nuclear membrane part(GO:0044453) |
0.1 | 0.1 | GO:0044299 | C-fiber(GO:0044299) |
0.1 | 1.7 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
0.1 | 0.5 | GO:0070847 | core mediator complex(GO:0070847) |
0.1 | 1.6 | GO:0060170 | ciliary membrane(GO:0060170) |
0.1 | 0.2 | GO:0098536 | deuterosome(GO:0098536) |
0.1 | 0.3 | GO:1990130 | Iml1 complex(GO:1990130) |
0.1 | 0.2 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.1 | 0.4 | GO:0002177 | manchette(GO:0002177) |
0.1 | 0.8 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
0.1 | 0.4 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.1 | 0.1 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.1 | 0.1 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
0.1 | 0.6 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.1 | 0.4 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.1 | 0.1 | GO:0034705 | potassium channel complex(GO:0034705) |
0.1 | 300.1 | GO:0016021 | integral component of membrane(GO:0016021) |
0.1 | 0.7 | GO:0042555 | MCM complex(GO:0042555) |
0.1 | 0.1 | GO:0098644 | complex of collagen trimers(GO:0098644) |
0.1 | 0.2 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
0.0 | 0.2 | GO:0097651 | phosphatidylinositol 3-kinase complex, class I(GO:0097651) |
0.0 | 0.4 | GO:0001673 | male germ cell nucleus(GO:0001673) |
0.0 | 0.1 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.0 | 0.2 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
0.0 | 0.5 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.0 | 0.4 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.0 | 0.1 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
0.0 | 0.1 | GO:0032021 | NELF complex(GO:0032021) |
0.0 | 0.0 | GO:0000798 | nuclear cohesin complex(GO:0000798) |
0.0 | 0.9 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.0 | 0.1 | GO:0000800 | lateral element(GO:0000800) |
0.0 | 0.0 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
0.0 | 0.1 | GO:0030681 | nucleolar ribonuclease P complex(GO:0005655) ribonuclease P complex(GO:0030677) multimeric ribonuclease P complex(GO:0030681) |
0.0 | 0.0 | GO:0005838 | proteasome regulatory particle(GO:0005838) |
0.0 | 0.0 | GO:0033177 | proton-transporting two-sector ATPase complex, proton-transporting domain(GO:0033177) |
0.0 | 0.3 | GO:0035861 | site of double-strand break(GO:0035861) |
0.0 | 0.0 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.0 | 0.1 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.0 | 0.1 | GO:0097209 | epidermal lamellar body(GO:0097209) |
0.0 | 0.1 | GO:0089701 | U2AF(GO:0089701) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.5 | 16.6 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
4.2 | 12.6 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
3.7 | 11.2 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
3.5 | 10.5 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
3.1 | 3.1 | GO:0098821 | BMP receptor activity(GO:0098821) |
3.1 | 9.2 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
2.8 | 13.8 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
2.6 | 7.7 | GO:0051718 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) DNA (cytosine-5-)-methyltransferase activity, acting on CpG substrates(GO:0051718) |
2.5 | 12.6 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
2.5 | 7.4 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
2.5 | 17.2 | GO:0003680 | AT DNA binding(GO:0003680) |
2.4 | 7.2 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
2.4 | 11.8 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
2.4 | 7.1 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
2.3 | 18.2 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) |
2.2 | 13.2 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
2.1 | 10.7 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
2.1 | 8.5 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
2.1 | 4.1 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
2.1 | 6.2 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
2.0 | 12.1 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
2.0 | 5.9 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
1.9 | 9.7 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
1.9 | 7.6 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
1.9 | 7.5 | GO:0008502 | melatonin receptor activity(GO:0008502) |
1.9 | 5.6 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
1.8 | 3.7 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
1.8 | 9.2 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
1.8 | 14.4 | GO:0098988 | G-protein coupled glutamate receptor activity(GO:0098988) |
1.8 | 7.1 | GO:0038064 | collagen receptor activity(GO:0038064) |
1.8 | 24.8 | GO:0005234 | extracellular-glutamate-gated ion channel activity(GO:0005234) |
1.7 | 12.2 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
1.7 | 12.0 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
1.7 | 3.4 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
1.7 | 5.1 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
1.7 | 5.0 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
1.6 | 4.9 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
1.6 | 4.8 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
1.6 | 14.1 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
1.6 | 6.2 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
1.5 | 19.8 | GO:0050811 | GABA receptor binding(GO:0050811) |
1.5 | 1.5 | GO:0051870 | methotrexate binding(GO:0051870) |
1.5 | 6.0 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
1.5 | 6.0 | GO:0097001 | ceramide binding(GO:0097001) |
1.5 | 4.4 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
1.5 | 7.3 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
1.4 | 5.7 | GO:0034056 | estrogen response element binding(GO:0034056) |
1.4 | 2.8 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
1.4 | 4.2 | GO:0004471 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) |
1.4 | 18.1 | GO:0031005 | filamin binding(GO:0031005) |
1.4 | 8.3 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
1.4 | 4.1 | GO:0042731 | PH domain binding(GO:0042731) |
1.4 | 4.1 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
1.3 | 4.0 | GO:0030284 | estrogen receptor activity(GO:0030284) |
1.3 | 8.0 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
1.3 | 17.0 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
1.3 | 3.9 | GO:1990460 | leptin receptor binding(GO:1990460) |
1.3 | 5.2 | GO:1990459 | transferrin receptor binding(GO:1990459) |
1.3 | 8.9 | GO:0034711 | inhibin binding(GO:0034711) |
1.2 | 3.7 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
1.2 | 10.9 | GO:0016920 | pyroglutamyl-peptidase activity(GO:0016920) |
1.2 | 8.3 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
1.1 | 12.6 | GO:0005522 | profilin binding(GO:0005522) |
1.1 | 1.1 | GO:0045340 | mercury ion binding(GO:0045340) |
1.1 | 3.4 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
1.1 | 8.0 | GO:0005167 | neurotrophin TRK receptor binding(GO:0005167) |
1.1 | 9.1 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
1.1 | 4.4 | GO:0046870 | cadmium ion binding(GO:0046870) |
1.1 | 4.4 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
1.1 | 3.3 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
1.1 | 3.2 | GO:0015157 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
1.1 | 9.7 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
1.1 | 3.2 | GO:0016728 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
1.1 | 4.3 | GO:0004969 | histamine receptor activity(GO:0004969) |
1.1 | 4.2 | GO:0004985 | opioid receptor activity(GO:0004985) |
1.0 | 3.1 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
1.0 | 5.1 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
1.0 | 1.0 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
1.0 | 29.6 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
1.0 | 3.8 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
1.0 | 2.9 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
1.0 | 2.9 | GO:0015186 | L-asparagine transmembrane transporter activity(GO:0015182) L-glutamine transmembrane transporter activity(GO:0015186) |
0.9 | 3.8 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
0.9 | 3.7 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
0.9 | 24.3 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.9 | 1.9 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
0.9 | 2.8 | GO:0000309 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.9 | 3.6 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
0.9 | 2.6 | GO:0070052 | collagen V binding(GO:0070052) |
0.9 | 6.8 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.9 | 4.3 | GO:0004690 | cyclic nucleotide-dependent protein kinase activity(GO:0004690) |
0.8 | 2.5 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.8 | 10.1 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.8 | 2.5 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.8 | 3.3 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
0.8 | 4.9 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) |
0.8 | 0.8 | GO:0005280 | hydrogen:amino acid symporter activity(GO:0005280) |
0.8 | 1.6 | GO:0030172 | troponin C binding(GO:0030172) |
0.8 | 3.3 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.8 | 0.8 | GO:0004952 | dopamine neurotransmitter receptor activity(GO:0004952) |
0.8 | 10.5 | GO:0004467 | long-chain fatty acid-CoA ligase activity(GO:0004467) |
0.8 | 14.4 | GO:1905030 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.8 | 4.0 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.8 | 8.7 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.8 | 20.6 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.8 | 13.4 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.8 | 3.9 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.8 | 4.6 | GO:0048495 | Roundabout binding(GO:0048495) |
0.8 | 2.3 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.8 | 1.5 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
0.8 | 2.3 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.8 | 5.3 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.8 | 14.3 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.7 | 1.5 | GO:0015087 | cobalt ion transmembrane transporter activity(GO:0015087) |
0.7 | 2.2 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.7 | 2.9 | GO:0038132 | neuregulin binding(GO:0038132) |
0.7 | 2.9 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
0.7 | 7.9 | GO:0030955 | potassium ion binding(GO:0030955) |
0.7 | 9.3 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
0.7 | 2.8 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.7 | 3.5 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.7 | 4.8 | GO:0102338 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.7 | 4.1 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.7 | 2.0 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
0.7 | 8.8 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.7 | 4.7 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.7 | 2.0 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.7 | 0.7 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
0.6 | 1.9 | GO:0035939 | microsatellite binding(GO:0035939) |
0.6 | 15.4 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
0.6 | 3.2 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
0.6 | 2.5 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.6 | 1.9 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.6 | 1.2 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
0.6 | 1.9 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
0.6 | 6.8 | GO:0005272 | sodium channel activity(GO:0005272) |
0.6 | 4.3 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.6 | 1.8 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.6 | 1.2 | GO:0004779 | sulfate adenylyltransferase activity(GO:0004779) |
0.6 | 2.4 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.6 | 3.0 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.6 | 13.0 | GO:0044688 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) photoreceptor cyclic-nucleotide phosphodiesterase activity(GO:0004120) 7,8-dihydro-D-neopterin 2',3'-cyclic phosphate phosphodiesterase activity(GO:0044688) inositol phosphosphingolipid phospholipase activity(GO:0052712) inositol phosphorylceramide phospholipase activity(GO:0052713) mannosyl-inositol phosphorylceramide phospholipase activity(GO:0052714) mannosyl-diinositol phosphorylceramide phospholipase activity(GO:0052715) |
0.6 | 2.9 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.6 | 21.1 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.6 | 2.3 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.6 | 0.6 | GO:0022840 | leak channel activity(GO:0022840) narrow pore channel activity(GO:0022842) |
0.6 | 1.7 | GO:0033142 | progesterone receptor binding(GO:0033142) |
0.6 | 1.7 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
0.6 | 5.0 | GO:0005313 | L-glutamate transmembrane transporter activity(GO:0005313) acidic amino acid transmembrane transporter activity(GO:0015172) |
0.6 | 7.2 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.6 | 1.1 | GO:0048763 | ryanodine-sensitive calcium-release channel activity(GO:0005219) calcium-induced calcium release activity(GO:0048763) |
0.5 | 3.3 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
0.5 | 1.6 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.5 | 2.7 | GO:0008035 | high-density lipoprotein particle binding(GO:0008035) |
0.5 | 4.3 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.5 | 1.1 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.5 | 4.2 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
0.5 | 1.6 | GO:0016151 | nickel cation binding(GO:0016151) |
0.5 | 2.6 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.5 | 2.6 | GO:1990254 | keratin filament binding(GO:1990254) |
0.5 | 6.8 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.5 | 22.1 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.5 | 0.5 | GO:0038191 | neuropilin binding(GO:0038191) |
0.5 | 2.5 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.5 | 4.1 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.5 | 8.6 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.5 | 2.5 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.5 | 5.4 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
0.5 | 1.0 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.5 | 6.8 | GO:0030507 | spectrin binding(GO:0030507) |
0.5 | 0.5 | GO:0004676 | 3-phosphoinositide-dependent protein kinase activity(GO:0004676) |
0.5 | 9.6 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.5 | 1.9 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.5 | 1.9 | GO:0005294 | neutral L-amino acid secondary active transmembrane transporter activity(GO:0005294) glycine:sodium symporter activity(GO:0015375) |
0.5 | 4.7 | GO:0022821 | sodium:proton antiporter activity(GO:0015385) potassium:proton antiporter activity(GO:0015386) potassium ion antiporter activity(GO:0022821) |
0.5 | 3.7 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.5 | 2.3 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.4 | 1.8 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.4 | 34.8 | GO:0019955 | cytokine binding(GO:0019955) |
0.4 | 6.1 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.4 | 1.8 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.4 | 1.3 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.4 | 1.3 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.4 | 4.8 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.4 | 12.0 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.4 | 8.6 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.4 | 0.9 | GO:0051373 | FATZ binding(GO:0051373) |
0.4 | 4.7 | GO:0015643 | toxic substance binding(GO:0015643) |
0.4 | 0.4 | GO:0046921 | alpha-(1->6)-fucosyltransferase activity(GO:0046921) |
0.4 | 1.3 | GO:2001069 | glycogen binding(GO:2001069) |
0.4 | 1.3 | GO:0031711 | bradykinin receptor binding(GO:0031711) |
0.4 | 1.7 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.4 | 2.5 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.4 | 2.5 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) |
0.4 | 2.1 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.4 | 0.8 | GO:0097016 | L27 domain binding(GO:0097016) |
0.4 | 3.3 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
0.4 | 16.7 | GO:0005267 | potassium channel activity(GO:0005267) |
0.4 | 2.0 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.4 | 26.6 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
0.4 | 0.4 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.4 | 4.3 | GO:0003785 | actin monomer binding(GO:0003785) |
0.4 | 1.9 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.4 | 1.9 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
0.4 | 1.1 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.4 | 3.0 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.4 | 3.0 | GO:0016004 | phospholipase activator activity(GO:0016004) |
0.4 | 2.6 | GO:0043495 | protein anchor(GO:0043495) |
0.4 | 1.5 | GO:0019145 | aminobutyraldehyde dehydrogenase activity(GO:0019145) 4-trimethylammoniobutyraldehyde dehydrogenase activity(GO:0047105) |
0.4 | 3.7 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.4 | 1.1 | GO:0009041 | uridylate kinase activity(GO:0009041) |
0.4 | 5.4 | GO:0004889 | acetylcholine-activated cation-selective channel activity(GO:0004889) |
0.4 | 0.4 | GO:0008066 | glutamate receptor activity(GO:0008066) |
0.4 | 2.5 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.4 | 0.7 | GO:0015142 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.4 | 13.1 | GO:0004394 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) heparan sulfate 2-O-sulfotransferase activity(GO:0004394) HNK-1 sulfotransferase activity(GO:0016232) heparan sulfate 6-O-sulfotransferase activity(GO:0017095) trans-9R,10R-dihydrodiolphenanthrene sulfotransferase activity(GO:0018721) 1-phenanthrol sulfotransferase activity(GO:0018722) 3-phenanthrol sulfotransferase activity(GO:0018723) 4-phenanthrol sulfotransferase activity(GO:0018724) trans-3,4-dihydrodiolphenanthrene sulfotransferase activity(GO:0018725) 9-phenanthrol sulfotransferase activity(GO:0018726) 2-phenanthrol sulfotransferase activity(GO:0018727) phenanthrol sulfotransferase activity(GO:0019111) 1-hydroxypyrene sulfotransferase activity(GO:0034930) proteoglycan sulfotransferase activity(GO:0050698) cholesterol sulfotransferase activity(GO:0051922) hydroxyjasmonate sulfotransferase activity(GO:0080131) |
0.4 | 1.1 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
0.4 | 2.5 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
0.3 | 0.7 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.3 | 1.0 | GO:0070840 | dynein complex binding(GO:0070840) |
0.3 | 1.0 | GO:0032139 | dinucleotide insertion or deletion binding(GO:0032139) |
0.3 | 1.0 | GO:0000832 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
0.3 | 7.8 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.3 | 2.4 | GO:0103116 | alpha-D-galactofuranose transporter activity(GO:0103116) |
0.3 | 1.3 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.3 | 2.6 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.3 | 1.6 | GO:0043426 | MRF binding(GO:0043426) |
0.3 | 3.8 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.3 | 0.9 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.3 | 0.9 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.3 | 26.4 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.3 | 2.6 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.3 | 8.5 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.3 | 5.2 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
0.3 | 0.9 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
0.3 | 14.2 | GO:0017022 | myosin binding(GO:0017022) |
0.3 | 1.1 | GO:0001602 | pancreatic polypeptide receptor activity(GO:0001602) |
0.3 | 0.9 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.3 | 2.0 | GO:0033691 | sialic acid binding(GO:0033691) |
0.3 | 1.4 | GO:0008410 | CoA-transferase activity(GO:0008410) |
0.3 | 1.9 | GO:0003896 | DNA primase activity(GO:0003896) |
0.3 | 1.1 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.3 | 3.6 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.3 | 1.6 | GO:0070191 | methionine-R-sulfoxide reductase activity(GO:0070191) |
0.3 | 5.2 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.3 | 0.5 | GO:0019211 | phosphatase activator activity(GO:0019211) |
0.3 | 1.1 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.3 | 2.1 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.3 | 4.9 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.3 | 0.5 | GO:0043199 | sulfate binding(GO:0043199) |
0.3 | 1.0 | GO:0034584 | piRNA binding(GO:0034584) |
0.2 | 1.2 | GO:0048185 | activin binding(GO:0048185) |
0.2 | 1.0 | GO:0071253 | connexin binding(GO:0071253) |
0.2 | 3.6 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.2 | 2.4 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.2 | 1.2 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
0.2 | 1.0 | GO:0015265 | urea channel activity(GO:0015265) |
0.2 | 1.9 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.2 | 0.9 | GO:0005217 | intracellular ligand-gated ion channel activity(GO:0005217) |
0.2 | 0.5 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.2 | 0.9 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.2 | 0.7 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.2 | 2.0 | GO:0098599 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.2 | 2.9 | GO:0055106 | ligase regulator activity(GO:0055103) ubiquitin-protein transferase regulator activity(GO:0055106) |
0.2 | 1.1 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.2 | 4.8 | GO:0050699 | WW domain binding(GO:0050699) |
0.2 | 1.1 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
0.2 | 1.9 | GO:0016215 | acyl-CoA desaturase activity(GO:0016215) |
0.2 | 0.4 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.2 | 1.1 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.2 | 1.3 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
0.2 | 2.1 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.2 | 1.3 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
0.2 | 0.8 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.2 | 0.8 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.2 | 1.0 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.2 | 0.6 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.2 | 3.4 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.2 | 19.9 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.2 | 3.0 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.2 | 2.2 | GO:0043274 | phospholipase binding(GO:0043274) |
0.2 | 2.1 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.2 | 2.7 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.2 | 5.3 | GO:0070888 | E-box binding(GO:0070888) |
0.2 | 4.7 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) |
0.2 | 5.4 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.2 | 0.6 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.2 | 0.6 | GO:0002046 | opsin binding(GO:0002046) |
0.2 | 0.5 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) |
0.2 | 0.9 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.2 | 2.1 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.2 | 1.5 | GO:0015166 | polyol transmembrane transporter activity(GO:0015166) |
0.2 | 1.0 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.2 | 0.3 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
0.2 | 1.0 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.2 | 0.8 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.2 | 0.2 | GO:0042281 | dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase activity(GO:0042281) |
0.2 | 2.0 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
0.2 | 2.0 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.2 | 0.5 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
0.2 | 2.3 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.2 | 0.5 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.2 | 1.0 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.2 | 3.9 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.2 | 0.3 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
0.2 | 1.5 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.2 | 0.6 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.2 | 0.8 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.2 | 1.1 | GO:0005112 | Notch binding(GO:0005112) |
0.1 | 1.6 | GO:0070402 | NADPH binding(GO:0070402) |
0.1 | 0.4 | GO:0008147 | structural constituent of bone(GO:0008147) |
0.1 | 3.1 | GO:0090599 | alpha-glucosidase activity(GO:0090599) |
0.1 | 0.6 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
0.1 | 0.5 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.1 | 1.4 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.1 | 2.3 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.1 | 0.6 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.1 | 0.5 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.1 | 54.0 | GO:0005509 | calcium ion binding(GO:0005509) |
0.1 | 1.9 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.1 | 0.3 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
0.1 | 1.1 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.1 | 0.5 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.1 | 0.4 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.1 | 0.1 | GO:0051378 | serotonin binding(GO:0051378) |
0.1 | 0.4 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
0.1 | 1.4 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.1 | 0.7 | GO:0004774 | succinate-CoA ligase activity(GO:0004774) |
0.1 | 0.5 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.1 | 0.7 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.1 | 0.4 | GO:0030957 | Tat protein binding(GO:0030957) |
0.1 | 1.3 | GO:0043733 | alkylbase DNA N-glycosylase activity(GO:0003905) DNA-3-methylbase glycosylase activity(GO:0043733) |
0.1 | 0.2 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
0.1 | 1.7 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.1 | 0.5 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.1 | 0.1 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
0.1 | 0.2 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
0.1 | 0.1 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.1 | 0.5 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.1 | 0.3 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.1 | 0.3 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
0.1 | 0.4 | GO:0004629 | phosphatidylinositol phospholipase C activity(GO:0004435) phospholipase C activity(GO:0004629) |
0.1 | 1.1 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.1 | 0.4 | GO:0031720 | haptoglobin binding(GO:0031720) |
0.1 | 0.4 | GO:0050543 | icosatetraenoic acid binding(GO:0050543) |
0.1 | 0.3 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.1 | 0.4 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
0.1 | 3.2 | GO:0051219 | phosphoprotein binding(GO:0051219) |
0.1 | 0.3 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.1 | 2.4 | GO:0019894 | kinesin binding(GO:0019894) |
0.1 | 0.3 | GO:0015464 | acetylcholine receptor activity(GO:0015464) |
0.1 | 2.5 | GO:0070330 | aromatase activity(GO:0070330) |
0.1 | 0.2 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.1 | 1.0 | GO:0030275 | LRR domain binding(GO:0030275) |
0.1 | 0.1 | GO:0000702 | oxidized base lesion DNA N-glycosylase activity(GO:0000702) |
0.1 | 1.0 | GO:0015295 | solute:proton symporter activity(GO:0015295) |
0.1 | 0.2 | GO:0000403 | Y-form DNA binding(GO:0000403) |
0.1 | 1.0 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.1 | 0.9 | GO:0008796 | bis(5'-nucleosyl)-tetraphosphatase activity(GO:0008796) |
0.1 | 0.2 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.1 | 0.8 | GO:0030276 | clathrin binding(GO:0030276) |
0.1 | 0.4 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.1 | 0.1 | GO:0031721 | hemoglobin alpha binding(GO:0031721) |
0.1 | 0.5 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.1 | 0.3 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.1 | 2.7 | GO:0019003 | GDP binding(GO:0019003) |
0.1 | 0.7 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.1 | 0.9 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.1 | 0.1 | GO:0008193 | RNA guanylyltransferase activity(GO:0008192) tRNA guanylyltransferase activity(GO:0008193) |
0.1 | 0.1 | GO:0030943 | mitochondrion targeting sequence binding(GO:0030943) |
0.1 | 0.1 | GO:0019153 | protein-disulfide reductase (glutathione) activity(GO:0019153) |
0.1 | 0.1 | GO:0045503 | dynein light chain binding(GO:0045503) |
0.1 | 1.4 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.1 | 0.2 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) |
0.1 | 0.2 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
0.1 | 0.5 | GO:0051393 | alpha-actinin binding(GO:0051393) |
0.1 | 0.3 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) |
0.1 | 0.3 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.1 | 0.2 | GO:0017108 | 5'-flap endonuclease activity(GO:0017108) |
0.1 | 0.6 | GO:0035198 | miRNA binding(GO:0035198) |
0.1 | 0.9 | GO:0008235 | metalloexopeptidase activity(GO:0008235) |
0.0 | 0.2 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.0 | 0.2 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.0 | 0.0 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
0.0 | 0.1 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.0 | 0.4 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
0.0 | 0.1 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
0.0 | 0.3 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.0 | 0.3 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.0 | 0.4 | GO:0031559 | oxidosqualene cyclase activity(GO:0031559) |
0.0 | 0.1 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.0 | 0.8 | GO:0017046 | peptide hormone binding(GO:0017046) |
0.0 | 0.1 | GO:0048019 | receptor antagonist activity(GO:0048019) |
0.0 | 0.5 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.0 | 0.7 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
0.0 | 0.1 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.0 | 0.1 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.0 | 0.0 | GO:0015927 | trehalase activity(GO:0015927) |
0.0 | 0.2 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
0.0 | 0.2 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.0 | 0.8 | GO:0043826 | N-ethylmaleimide reductase activity(GO:0008748) reduced coenzyme F420 dehydrogenase activity(GO:0043738) sulfur oxygenase reductase activity(GO:0043826) malolactic enzyme activity(GO:0043883) epoxyqueuosine reductase activity(GO:0052693) |
0.0 | 0.1 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.0 | 0.1 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.0 | 0.1 | GO:0004144 | diacylglycerol O-acyltransferase activity(GO:0004144) |
0.0 | 0.5 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
0.0 | 0.0 | GO:0031402 | sodium ion binding(GO:0031402) |
0.0 | 11.8 | GO:0004930 | G-protein coupled receptor activity(GO:0004930) |
0.0 | 0.1 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.0 | 0.0 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.0 | 0.1 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
0.0 | 0.1 | GO:0019862 | IgA binding(GO:0019862) |
0.0 | 0.0 | GO:0031420 | alkali metal ion binding(GO:0031420) |
0.0 | 0.1 | GO:0052851 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
0.0 | 0.0 | GO:0070699 | type II activin receptor binding(GO:0070699) |
0.0 | 0.1 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.0 | 0.1 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.0 | 0.0 | GO:0035870 | dITP diphosphatase activity(GO:0035870) |
0.0 | 0.1 | GO:0015037 | peptide disulfide oxidoreductase activity(GO:0015037) |
0.0 | 0.1 | GO:0008390 | testosterone 16-alpha-hydroxylase activity(GO:0008390) |
0.0 | 0.0 | GO:0001962 | alpha-1,3-galactosyltransferase activity(GO:0001962) |
0.0 | 0.0 | GO:0098634 | protein binding involved in cell-matrix adhesion(GO:0098634) |
0.0 | 0.0 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
0.0 | 0.0 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
0.0 | 0.0 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.2 | 17.9 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.9 | 1.8 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.8 | 0.8 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.8 | 19.1 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.8 | 8.7 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.8 | 22.5 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.7 | 17.8 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.7 | 2.0 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.6 | 12.9 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.5 | 5.8 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.5 | 0.5 | PID IGF1 PATHWAY | IGF1 pathway |
0.5 | 5.9 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.4 | 10.4 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.4 | 1.3 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.4 | 13.0 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.4 | 1.2 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.4 | 6.8 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.4 | 7.5 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.4 | 4.8 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.3 | 2.9 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.3 | 1.5 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.3 | 78.8 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.3 | 6.9 | PID AURORA A PATHWAY | Aurora A signaling |
0.3 | 9.5 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.3 | 0.5 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.3 | 3.4 | PID REELIN PATHWAY | Reelin signaling pathway |
0.3 | 6.1 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.3 | 2.8 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.3 | 1.0 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.2 | 0.2 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.2 | 1.9 | PID FOXO PATHWAY | FoxO family signaling |
0.2 | 0.2 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.2 | 0.2 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.2 | 3.4 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.2 | 0.9 | PID ENDOTHELIN PATHWAY | Endothelins |
0.2 | 1.0 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.2 | 0.2 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.2 | 2.7 | PID ARF 3PATHWAY | Arf1 pathway |
0.2 | 3.7 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.2 | 1.9 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.1 | 1.5 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.1 | 3.6 | PID BARD1 PATHWAY | BARD1 signaling events |
0.1 | 2.1 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.1 | 0.1 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.1 | 1.7 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.1 | 0.2 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.1 | 3.4 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.1 | 0.3 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.1 | 4.5 | NABA COLLAGENS | Genes encoding collagen proteins |
0.1 | 1.1 | ST GAQ PATHWAY | G alpha q Pathway |
0.1 | 0.3 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.1 | 0.1 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.1 | 0.3 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.1 | 10.5 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.1 | 0.4 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.1 | 0.8 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.1 | 1.2 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.0 | 0.1 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.0 | 0.1 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.3 | 3.3 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
2.3 | 2.3 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
2.3 | 31.5 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
2.0 | 23.7 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
1.8 | 47.4 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
1.7 | 18.7 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
1.6 | 23.9 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
1.6 | 26.8 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
1.4 | 12.6 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
1.3 | 56.5 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
1.2 | 1.2 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
1.1 | 8.5 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
1.1 | 2.1 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
1.0 | 14.5 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
1.0 | 12.4 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
1.0 | 1.0 | REACTOME SIGNALING BY NOTCH3 | Genes involved in Signaling by NOTCH3 |
1.0 | 22.4 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
1.0 | 7.7 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.8 | 17.6 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.8 | 3.1 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.8 | 3.1 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.8 | 13.0 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.7 | 6.6 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.7 | 9.8 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.7 | 1.3 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.7 | 17.4 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.7 | 12.7 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.6 | 7.7 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.6 | 11.2 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.6 | 7.6 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.6 | 8.2 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.6 | 1.7 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.5 | 10.2 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.5 | 5.7 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.5 | 1.5 | REACTOME FGFR1 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR1 ligand binding and activation |
0.5 | 6.6 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.5 | 5.6 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.5 | 5.6 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.5 | 4.1 | REACTOME PEPTIDE HORMONE BIOSYNTHESIS | Genes involved in Peptide hormone biosynthesis |
0.4 | 9.7 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.4 | 0.4 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.4 | 0.9 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.4 | 5.0 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
0.4 | 5.4 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.4 | 0.4 | REACTOME PLC BETA MEDIATED EVENTS | Genes involved in PLC beta mediated events |
0.4 | 5.9 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.4 | 4.7 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.4 | 5.3 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.4 | 6.0 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.4 | 4.0 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.4 | 6.4 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.4 | 13.0 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.3 | 2.7 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.3 | 5.1 | REACTOME POST NMDA RECEPTOR ACTIVATION EVENTS | Genes involved in Post NMDA receptor activation events |
0.3 | 10.8 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.3 | 11.3 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.3 | 3.1 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.3 | 1.2 | REACTOME FATTY ACYL COA BIOSYNTHESIS | Genes involved in Fatty Acyl-CoA Biosynthesis |
0.3 | 5.5 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.3 | 6.3 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.3 | 5.2 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.3 | 3.0 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.2 | 1.5 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.2 | 1.2 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.2 | 0.2 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.2 | 1.8 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.2 | 6.2 | REACTOME ION CHANNEL TRANSPORT | Genes involved in Ion channel transport |
0.2 | 1.9 | REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
0.2 | 1.0 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.2 | 0.8 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.2 | 1.0 | REACTOME NRIF SIGNALS CELL DEATH FROM THE NUCLEUS | Genes involved in NRIF signals cell death from the nucleus |
0.2 | 0.6 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.2 | 13.1 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.2 | 5.5 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.2 | 3.0 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.2 | 1.1 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.2 | 0.2 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
0.2 | 1.2 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.2 | 0.9 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.2 | 2.9 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
0.2 | 3.0 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.2 | 1.0 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.2 | 1.0 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.2 | 0.8 | REACTOME SHC MEDIATED SIGNALLING | Genes involved in SHC-mediated signalling |
0.2 | 0.2 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.1 | 2.0 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.1 | 2.5 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.1 | 0.5 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.1 | 0.7 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.1 | 2.1 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.1 | 3.0 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.1 | 0.5 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.1 | 1.8 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.1 | 0.1 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.1 | 0.6 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.1 | 6.3 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.1 | 0.5 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.1 | 2.0 | REACTOME KERATAN SULFATE KERATIN METABOLISM | Genes involved in Keratan sulfate/keratin metabolism |
0.1 | 1.2 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
0.1 | 0.3 | REACTOME ASPARAGINE N LINKED GLYCOSYLATION | Genes involved in Asparagine N-linked glycosylation |
0.1 | 1.4 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.1 | 0.8 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |
0.1 | 0.1 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.1 | 0.4 | REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
0.1 | 0.2 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.1 | 0.9 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.1 | 0.2 | REACTOME VIRAL MESSENGER RNA SYNTHESIS | Genes involved in Viral Messenger RNA Synthesis |
0.1 | 12.3 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.1 | 1.0 | REACTOME NEURONAL SYSTEM | Genes involved in Neuronal System |
0.1 | 0.1 | REACTOME ACTIVATED POINT MUTANTS OF FGFR2 | Genes involved in Activated point mutants of FGFR2 |
0.1 | 0.4 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
0.1 | 1.5 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.1 | 0.3 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
0.1 | 1.7 | REACTOME EXTRACELLULAR MATRIX ORGANIZATION | Genes involved in Extracellular matrix organization |
0.1 | 3.4 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.1 | 0.9 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
0.1 | 0.2 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
0.1 | 0.5 | REACTOME OPSINS | Genes involved in Opsins |
0.1 | 0.9 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.1 | 0.1 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
0.0 | 0.0 | REACTOME SHC RELATED EVENTS | Genes involved in SHC-related events |
0.0 | 0.7 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.0 | 0.3 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
0.0 | 0.2 | REACTOME SIGNALLING BY NGF | Genes involved in Signalling by NGF |
0.0 | 0.7 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.0 | 0.2 | REACTOME APOPTOTIC EXECUTION PHASE | Genes involved in Apoptotic execution phase |
0.0 | 0.3 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.0 | 0.3 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.0 | 0.7 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
0.0 | 0.1 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.0 | 0.4 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.0 | 0.0 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.0 | 0.2 | REACTOME AMYLOIDS | Genes involved in Amyloids |